Publications

1. Agudelo MC, Agudelo S, Lorincz A, Ramírez AT, Castañeda KM, Garcés-Palacio I, et al. (2024). Folate deficiency modifies the risk of CIN3+ associated with DNA methylation levels: a nested case-control study from the ASCUS-COL trial. Eur J Nutr. 63(2):563–72. https://doi.org/10.1007/s00394-023-03289-4 PMID:38129362
2. Al-Soneidar WA, Harper S, Coutlée F, Gheit T, Tommasino M, Nicolau B (2024). Prevalence of Alpha, Beta, and Gamma Human Papillomaviruses in Patients With Head and Neck Cancer and Noncancer Controls and Relation to Behavioral Factors. J Infect Dis. 229(4):1088–96. https://doi.org/10.1093/infdis/jiad335 PMID:37584283
3. Beyer K, Leenen R, Venderbos LDF, Helleman J, Denijs F, Bramer W, et al.; The PRAISE-U Consortium (2024). Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium. J Pers Med. 14(1):12. https://doi.org/10.3390/jpm14010084 PMID:38248785
4. Boni SP, Tenet V, Horo A, Heideman DAM, Bleeker MCG, Tanon A, et al.; on behalf The IeDEA West Africa Collaboration (2024). High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Côte d’Ivoire, 2018 to 2020. Int J Cancer. 154(6):962–8. https://doi.org/10.1002/ijc.34774 PMID:37942579
5. Downham L, Jaafar I, Rol ML, Nyawira Nyaga V, Valls J, Baena A, et al. (2024). Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis. Br J Cancer. 130(4):517–25. https://doi.org/10.1038/s41416-023-02490-w PMID:37973957
6. Dube Mandishora RS, Galati L, Reich RR, Combes JD, McKay-Chopin S, Makunike-Mutasa R, et al. (2024). Epstein-Barr Virus DNA Is Associated With Conjunctival Squamous Cell Carcinomas: A Case-Control Study From Zimbabwe. Open Forum Infect Dis. 11(4):ofae165. https://doi.org/10.1093/ofid/ofae165 PMID:38623569
7. Engels EA, Shiels MS, Barnabas RV, Bohlius J, Brennan P, Castilho J, et al. (2024). State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI. Int J Cancer. 154(4):596–606. https://doi.org/10.1002/ijc.34727 PMID:37715370
8. Fokom Domgue J, Dille I, Kapambwe S, Yu R, Gnangnon F, Chinula L, et al. (2024). HPV vaccination in Africa in the COVID-19 era: a cross-sectional survey of healthcare providers’ knowledge, training, and recommendation practices. Front Public Health. 12:1343064. https://doi.org/10.3389/fpubh.2024.1343064 PMID:38299075
9. Guigon L, Sánchez LXG, Petit AS, Bonniec AL, Basu P, Rodrigue CM, et al. (2024). Would shared decision-making be useful in breast cancer screening programmes? A qualitative study using focus group discussions to gather evidence from French women with different socioeconomic backgrounds. BMC Public Health. 24(1):404. https://doi.org/10.1186/s12889-024-17876-5 PMID:38326802
10. Hickey M, Basu P, Sassarini J, Stegmann ME, Weiderpass E, Nakawala Chilowa K, et al. (2024). Managing menopause after cancer. Lancet. 403(10430):984–96. https://doi.org/10.1016/S0140-6736(23)02802-7 PMID:38458217
11. Kamuyu G, Coelho da Silva F, Tenet V, Schussler J, Godi A, Herrero R, et al. (2024). Global evaluation of lineage-specific human papillomavirus capsid antigenicity using antibodies elicited by natural infection. Nat Commun. 15(1):1608. https://doi.org/10.1038/s41467-024-45807-w PMID:38383518
12. Kartsonaki C, Yao P, Butt J, Jeske R, de Martel C, Plummer M, et al. (2024). Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study. Int J Cancer. 154(8):1423–32. https://doi.org/10.1002/ijc.34814 PMID:38108203
13. Kayamba V, Munshi H, Hankolwe MN, Kaluba Kavimba C, Chongwe G, Knaze V, et al. (2024). Nationwide survey of Helicobacter pylori seropositivity and gastric atrophy in Zambia. Helicobacter. 29(3):e13096. https://doi.org/10.1111/hel.13096 PMID:38790093
14. Lehtinen M, Bruni L, Elfström M, Gray P, Logel M, Mariz FC, et al. (2024). Scientific approaches toward improving cervical cancer elimination strategies. Int J Cancer. 154(9):1537–48. https://doi.org/10.1002/ijc.34839 PMID:38196123
15. Lu Y, Clifford GM, Fairley CK, Grulich AE, Garland SM, Xiao F, et al. (2024). Human papillomavirus and p16^INK4a in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis. Int J Cancer. 154(5):830–41. https://doi.org/10.1002/ijc.34763 PMID:37861207
16. Maroui MA, Odongo GA, Mundo L, Manara F, Mure F, Fusil F, et al. (2024). Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell infection. Proc Natl Acad Sci U S A. 121(16):e2314426121. https://doi.org/10.1073/pnas.2314426121 PMID:38574017
17. Pennisi R, Trischitta P, Costa M, Venuti A, Tamburello MP, Sciortino MT (2024). Update of Natural Products and Their Derivatives Targeting Epstein-Barr Infection. Viruses. 16(1):20. https://doi.org/10.3390/v16010124 PMID:38257824
18. Rugge M, Genta RM, Malfertheiner P, Dinis-Ribeiro M, El-Serag H, Graham DY, et al.; RE.GA.IN; RE GA IN (2024). RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates. Gut. 73(3):407–41. https://doi.org/10.1136/gutjnl-2023-331164 PMID:38383142
19. Sichero L, Gonçalves MG, Bettoni F, Coser EM, Mota G, Nunes RAL, et al. (2024). Detection of serum biomarkers of HPV-16 driven oropharynx and oral cavity cancer in Brazil. Oral Oncol. 149:106676. https://doi.org/10.1016/j.oraloncology.2023.106676 PMID:38150987
20. Singini MG, Muchengeti M, Sitas F, Chen WC, Combes JD, Waterboer T, et al. (2024). Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status. Int J Cancer. 155(2):251–60. https://doi.org/10.1002/ijc.34919 PMID:38577820
21. Sjomina O, Poļaka I, Suhorukova J, Vangravs R, Paršutins S, Knaze V, et al. (2024). Randomised clinical trial: efficacy and safety of H. pylori eradication treatment with and without Saccharomyces boulardii supplementation. Eur J Cancer Prev. 33(3):217–22. https://doi.org/10.1097/CEJ.0000000000000858 PMID:37942999
22. Spindler L, Etienney I, Abramowitz L, de Parades V, Pigot F, Siproudhis L, et al.; Société Nationale Française de Colo-Proctologie (2024). Screening for precancerous anal lesions linked to human papillomaviruses: French recommendations for clinical practice. Tech Coloproctol. 28(1):23. https://doi.org/10.1007/s10151-023-02899-8 PMID:38198036
23. Steinberg J, Hughes S, Hui H, Allsop MJ, Egger S, David M, et al. (2024). Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: A systematic review and meta-analysis. Int J Cancer. 154(8):1394–412. https://doi.org/10.1002/ijc.34798 PMID:38083979
24. Stier EA, Clarke MA, Deshmukh AA, Wentzensen N, Liu Y, Poynten IM, et al. (2024). International Anal Neoplasia Society’s consensus guidelines for anal cancer screening. Int J Cancer. 154(10):1694–702. https://doi.org/10.1002/ijc.34850 PMID:38297406
25. Sun D, Mülder DT, Li Y, Nieboer D, Park JY, Suh M, et al. (2024). The Effect of Nationwide Organized Cancer Screening Programs on Gastric Cancer Mortality: A Synthetic Control Study. Gastroenterology. 166(3):503–14. https://doi.org/10.1053/j.gastro.2023.11.286 PMID:38007053
26. Almadi MA, Basu P (2023). Doing things right and doing the right things: Colorectal cancer screening in Saudi Arabia. Saudi J Gastroenterol. 29(2):67–70. https://doi.org/10.4103/sjg.sjg_82_23 PMID:36960528
27. Arbyn M, Costa S, Latsuzbaia A, Kellen E, Girogi Rossi P, Cocuzza CE, et al. (2023). HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions. Cancer Epidemiol Biomarkers Prev. 32(2):159–63. https://doi.org/10.1158/1055-9965.EPI-22-1041 PMID:36744312
28. Baena A, Mesher D, Salgado Y, Martínez S, Villalba GR, Amarilla ML, et al.; ESTAMPA study group (2023). Performance of visual inspection of the cervix with acetic acid (VIA) for triage of HPV screen-positive women: results from the ESTAMPA study. Int J Cancer. 152(8):1581–92. https://doi.org/10.1002/ijc.34384 PMID:36451311
29. Baena A, Paolino M, Villarreal-Garza C, Torres G, Delgado L, Ruiz R, et al. (2023). Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening. Cancer Epidemiol. 86 Suppl 1:102446. https://doi.org/10.1016/j.canep.2023.102446 PMID:37852728
30. Bhatla N, Muwonge R, Malvi SG, Joshi S, Poli URR, Lucas E, et al. (2023). Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine. Hum Vaccin Immunother. 19(3):2289242. https://doi.org/10.1080/21645515.2023.2289242 PMID:38078840
31. Borges PCC, Spencer HB, Barbosa C, Costa V, Furtado A, Leal MC, et al. (2023). XPERT^® breast cancer STRAT4 as an alternative method of identifying breast cancer phenotype in Cape Verde (preliminary results). Ecancermedicalscience. 17:1530. https://doi.org/10.3332/ecancer.2023.1530 PMID:37138965
32. Brevik TB, da Matta Calegari LR, Mosquera Metcalfe I, Laake P, Maza M, Basu P, et al. (2023). Training health care providers to administer VIA as a screening test for cervical cancer: a systematic review of essential training components. BMC Med Educ. 23(1):712. https://doi.org/10.1186/s12909-023-04711-5 PMID:37770904
33. Burger E, Baussano I, Kim JJ, Laprise JF, Berkhof J, Schiller JT, et al. (2023). Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptions. Vaccine. 41(16):2648–9. https://doi.org/10.1016/j.vaccine.2022.07.022 PMID:35941035
34. Ceraolo MG, Romero-Medina MC, Gobbato S, Melita G, Krynska H, Sirand C, et al. (2023). HPV38 impairs UV-induced transcriptional activation of the IL-18 pro-inflammatory cytokine. mSphere. 8(6):e0045023. https://doi.org/10.1128/msphere.00450-23 PMID:37877723
35. Clifford GM, Baussano I, Heideman DAM, Tshering S, Choden T, Lazzarato F, et al. (2023). Human papillomavirus testing on self-collected samples to detect high-grade cervical lesions in rural Bhutan: The REACH-Bhutan study. Cancer Med. 12(10):11828–37. https://doi.org/10.1002/cam4.5851 PMID:36999740
36. Clifford GM, Wei F (2023). Prevention of Human Papillomavirus-Related Anal Cancer in Women Living With Human Immunodeficiency Virus. J Infect Dis. 227(8):929–31. https://doi.org/10.1093/infdis/jiac399 PMID:36196561
37. Cui F, Blach S, Manzengo Mingiedi C, Gonzalez MA, Sabry Alaama A, Mozalevskis A, et al. (2023). Global reporting of progress towards elimination of hepatitis B and hepatitis C. Lancet Gastroenterol Hepatol. 8(4):332–42. https://doi.org/10.1016/S2468-1253(22)00386-7 PMID:36764320
38. Damgacioglu H, Lin YY, Ortiz AP, Wu CF, Shahmoradi Z, Shyu SS, et al. (2023). State Variation in Squamous Cell Carcinoma of the Anus Incidence and Mortality, and Association With HIV/AIDS and Smoking in the United States. J Clin Oncol. 41(6):1228–38. https://doi.org/10.1200/JCO.22.01390 PMID:36441987
39. Deshmukh AA, Damgacioglu H, Georges D, Sonawane K, Clifford GM (2023). Human Papillomavirus-Associated Anal Cancer Incidence and Burden Among US Men, According to Sexual Orientation, Human Immunodeficiency Virus Status, and Age. Clin Infect Dis. 77(3):419–24. https://doi.org/10.1093/cid/ciad205 PMID:37017078
40. Deshmukh AA, Damgacioglu H, Georges D, Sonawane K, Ferlay J, Bray F, et al. (2023). Global burden of HPV-attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: A worldwide analysis. Int J Cancer. 152(3):417–28. https://doi.org/10.1002/ijc.34269 PMID:36054026
41. Espina C, Feliu A, Maza M, Almonte M, Ferreccio C, Finck C, et al.; Working Groups of Scientific Experts (2023). Latin America and the Caribbean Code Against Cancer 1st Edition: 17 cancer prevention recommendations to the public and to policy-makers (World Code Against Cancer Framework). Cancer Epidemiol. 86 Suppl 1:102402. https://doi.org/10.1016/j.canep.2023.102402 PMID:37852725
42. Galati L, Gupta P, Tufaro A, Marinaro M, Saponaro C, Escobar Marcillo DI, et al. (2023). Evaluation of human papillomavirus DNA in colorectal cancer and adjacent mucosal tissue samples. Infect Agent Cancer. 18(1):71. https://doi.org/10.1186/s13027-023-00552-5 PMID:37941001
43. Gheit T, Muwonge R, Lucas E, Galati L, Anantharaman D, McKay-Chopin S, et al. (2023). Impact of HPV vaccination on HPV-related oral infections. Oral Oncol. 136:106244. https://doi.org/10.1016/j.oraloncology.2022.106244 PMID:36402055
44. Gómez Rivas J, Leenen RCA, Venderbos LDF, Helleman J, de la Parra I, Vasilyeva V, et al.; The PRAISE-U Consortium (2023). Navigating through the Controversies and Emerging Paradigms in Early Detection of Prostate Cancer: Bridging the Gap from Classic RCTs to Modern Population-Based Pilot Programs. J Pers Med. 13(12):13. https://doi.org/10.3390/jpm13121677 PMID:38138904
45. Gu J, He F, Clifford GM, Li M, Fan Z, Li X, et al. (2023). A systematic review and meta-analysis on the relative and attributable risk of Helicobacter pylori infection and cardia and non-cardia gastric cancer. Expert Rev Mol Diagn. 23(12):1251–61. https://doi.org/10.1080/14737159.2023.2277377 PMID:37905778
46. Hall MT, Simms KT, Murray JM, Keane A, Nguyen DTN, Caruana M, et al. (2023). Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV. Nat Med. 29(12):3059–66. https://doi.org/10.1038/s41591-023-02601-3 PMID:38087116
47. Hirabayashi M, Georges D, Clifford GM, de Martel C (2023). Estimating the Global Burden of Epstein-Barr Virus-Associated Gastric Cancer: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 21(4):922–930.e21. https://doi.org/10.1016/j.cgh.2022.07.042 PMID:35963539
48. Hirabayashi M, Traverse-Glehen A, Combes JD, Clifford GM, de Martel C (2023). Estimating the prevalence of Epstein-Barr virus in primary gastric lymphoma: a systematic review and meta-analysis. Infect Agent Cancer. 18(1):8. https://doi.org/10.1186/s13027-023-00482-2 PMID:36765388
49. Hu SY, Zhao XL, Zhao FH, Wei LH, Zhou Q, Niyazi M, et al. (2023). Implementation of visual inspection with acetic acid and Lugol’s iodine for cervical cancer screening in rural China. Int J Gynaecol Obstet. 160(2):571–8. https://doi.org/10.1002/ijgo.14368 PMID:35871356
50. Hu-Heimgartner K, Lang N, Ayme A, Ming C, Combes JD, Chappuis VN, et al. (2023). Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature. Fam Cancer. 22(3):283–9. https://doi.org/10.1007/s10689-023-00331-6 PMID:37119509
51. Ibrahim Khalil A, Zhang L, Muwonge R, Sauvaget C, Basu P (2023). Efficacy and safety of therapeutic HPV vaccines to treat CIN 2/CIN 3 lesions: a systematic review and meta-analysis of phase II/III clinical trials. BMJ Open. 13(10):e069616. https://doi.org/10.1136/bmjopen-2022-069616 PMID:37879679
52. Ikiroma A, Santin O, Camanda J, Chocolate F, Pelinganga O, Jordao H, et al. (2023). Evaluation of human papillomavirus (HPV) knowledge among healthcare professionals: A study of conference attendees in Angola. Glob Public Health. 18(1):2099931. https://doi.org/10.1080/17441692.2022.2099931 PMID:35849621
53. Joshi S, Anantharaman D, Muwonge R, Bhatla N, Panicker G, Butt J, et al. (2023). Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination. Vaccine. 41(1):236–45. https://doi.org/10.1016/j.vaccine.2022.11.044 PMID:36446654
54. Joshi S, Muwonge R, Kulkarni V, Mandolkar M, Lucas E, Pujari S, et al. (2023). Can we increase the cervical cancer screening interval with an HPV test for women living with HIV? Results of a cohort study from Maharashtra, India. Int J Cancer. 152(2):249–58. https://doi.org/10.1002/ijc.34221 PMID:35852007
55. Knaze V, Freisling H, Cook P, Heise K, Acevedo J, Cikutovic M, et al. (2023). Association between salt intake and gastric atrophy by Helicobacter pylori infection: first results from the Epidemiological Investigation of Gastric Malignancy (ENIGMA). Eur J Nutr. 62(5):2129–38. https://doi.org/10.1007/s00394-023-03132-w PMID:36964250
56. Kutz JM, Rausche P, Gheit T, Puradiredja DI, Fusco D (2023). Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review. BMC Public Health. 23(1):974. https://doi.org/10.1186/s12889-023-15842-1 PMID:37237329
57. Lang N, Ayme A, Ming C, Combes JD, Chappuis VN, Friedlaender A, et al. (2023). Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study. Swiss Med Wkly. 153(3):40055. https://doi.org/10.57187/smw.2023.40055 PMID:37011610
58. Li M, Park JY, Sheikh M, Kayamba V, Rumgay H, Jenab M, et al. (2023). Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time. Gut. 72(5):846–54. https://doi.org/10.1136/gutjnl-2022-328233 PMID:36241389
59. Liu Z, Lin C, Mao X, Guo C, Suo C, Zhu D, et al. (2023). Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people. Gut. 72(12):2354–63. https://doi.org/10.1136/gutjnl-2023-330691 PMID:37798085
60. Lucas E, Murillo R, Arrossi S, Bárcena M, Chami Y, Nessa A, et al. (2023). Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand. Elife. 12:e86527. https://doi.org/10.7554/eLife.86527 PMID:37191660
61. M de Carvalho T, Man I, Georges D, Saraswati LR, Bhandari P, Kataria I, et al. (2023). Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India. BMJ Glob Health. 8(11):e012580. https://doi.org/10.1136/bmjgh-2023-012580 PMID:37931940
62. Mallafré-Larrosa M, Ritchie D, Papi G, Mosquera I, Mensah K, Lucas E, et al.; CBIG-SCREEN Consortium (2023). Survey of current policies towards widening cervical screening coverage among vulnerable women in 22 European countries. Eur J Public Health. 33(3):502–8. https://doi.org/10.1093/eurpub/ckad055 PMID:37043751
63. Man I, Georges D, Bonjour M, Baussano I (2023). Approximating missing epidemiological data for cervical cancer through Footprinting: A case study in India. Elife. 12:e81752. https://doi.org/10.7554/eLife.81752 PMID:37227260
64. Man I, Georges D, Sankaranarayanan R, Basu P, Baussano I (2023). Building resilient cervical cancer prevention through gender-neutral HPV vaccination. Elife. 12:12. https://doi.org/10.7554/eLife.85735 PMID:37486822
65. Mosquera I, Barajas CB, Zhang L, Lucas E, Benitez Majano S, Maza M, et al. (2023). Assessment of organization of cervical and breast cancer screening programmes in the Latin American and the Caribbean states: The CanScreen5 framework. Cancer Med. 12(19):19935–48. https://doi.org/10.1002/cam4.6492 PMID:37768035
66. Mosquera I, Todd A, Balaj M, Zhang L, Benitez Majano S, Mensah K, et al. (2023). Components and effectiveness of patient navigation programmes to increase participation to breast, cervical and colorectal cancer screening: A systematic review. Cancer Med. 12(13):14584–611. https://doi.org/10.1002/cam4.6050 PMID:37245225
67. Mullapally SK, Basu P, Parikh P (2023). Prevention of Cervical Cancer through HPV Vaccination and Screening in Maldives. South Asian J Cancer. 12(1):44–6. https://doi.org/10.1055/s-0043-1764158 PMID:36851935
68. Ong SK, Abe SK, Thilagaratnam S, Haruyama R, Pathak R, Jayasekara H, et al. (2023). Towards elimination of cervical cancer – human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries. Lancet Reg Health West Pac. 39:100860. https://doi.org/10.1016/j.lanwpc.2023.100860 PMID:37576906
69. Oommen AM, Basu P, Cherian AG, Zomawia E, Manoharan R, Pricilla RA, et al.; SHE-CAN collaborators (2023). Protocol for the formative phase of a trial (SHE-CAN) to test co-designed implementation strategies for HPV-based cervical screening among vulnerable women in two diverse settings in India. Implement Sci Commun. 4(1):62. https://doi.org/10.1186/s43058-023-00436-0 PMID:37291627
70. Pham TM, Thanh NX, Ng N, Kubo T, Fujino Y, Matsuda S, et al. (2023). Average lifespan shortened due to cancer in selected countries of North America, Europe, Asia and Oceania, 2006 and 2016. Ann Epidemiol. 80:76–85. https://doi.org/10.1016/j.annepidem.2023.01.012 PMID:36717062
71. Ramadas K, Basu P, Mathew BS, Muwonge R, Venugopal M, Prakasan AM, et al. (2023). Effectiveness of triennial screening with clinical breast examination: 14-years follow-up outcomes of randomized clinical trial in Trivandrum, India. Cancer. 129(2):272–82. https://doi.org/10.1002/cncr.34526 PMID:36321193
72. Ramírez AT, Valls J, Baena A, Rojas FD, Ramírez K, Álvarez R, et al.; ESTAMPA Study Group (2023). Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study. Lancet Reg Health Am. 26:100593. https://doi.org/10.1016/j.lana.2023.100593 PMID:37766799
73. Salimzadeh H, Sauvaget C, Delavari A, Sadeghi A, Amani M, Salimzadeh S, et al. (2023). Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study. Arch Iran Med. 26(3):138–46. https://doi.org/10.34172/aim.2023.22 PMID:37543936
74. Sauvaget C, Boutayeb S, Bendahhou K, Selmouni F, Belbaraka R, Muwonge R, et al. (2023). The journey of cancer patients and the quest to equity: findings from Morocco. Public Health. 223:33–41. https://doi.org/10.1016/j.puhe.2023.07.015 PMID:37597462
75. Sauvaget C, Selmouni F, Dangbemey DP, Kpebo DDO, Dieng NM, Nkele NN, et al. (2023). Scaling-Up Cervical Cancer Screening and Treatment in Sub-Saharan Africa: Perspectives From Local Health Policymakers. JCO Glob Oncol. 9(9):e2300115. https://doi.org/10.1200/GO.23.00115 PMID:37441744
76. Sayinzoga F, Tenet V, Heideman DAM, Sibomana H, Umulisa MC, Franceschi S, et al. (2023). Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys. Lancet Glob Health. 11(7):e1096–104. https://doi.org/10.1016/S2214-109X(23)00193-6 PMID:37207683
77. Schuind AE, Rees H, Schiller J, Mugo N, Dull P, Barnabas R, et al. (2023). State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop. Prev Med Rep. 35:102331. https://doi.org/10.1016/j.pmedr.2023.102331 PMID:37576844
78. Shaji A, Keechilat P, Dk V, Sauvaget C (2023). Analysis of the Mortality Trends of 23 Major Cancers in the Indian Population Between 2000 and 2019: A Joinpoint Regression Analysis. JCO Glob Oncol. 9(9):e2200405. https://doi.org/10.1200/GO.22.00405 PMID:36947728
79. Sharma H, Parekh S, Pujari P, Shewale S, Desai S, Bhatla N, et al. (2023). Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial. Lancet Oncol. 24(12):1321–33. https://doi.org/10.1016/S1470-2045(23)00480-1 PMID:37949086
80. Simms KT, Keane A, Nguyen DTN, Caruana M, Hall MT, Lui G, et al. (2023). Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population. Nat Med. 29(12):3050–8. https://doi.org/10.1038/s41591-023-02600-4 PMID:38087115
81. Taghavi K, Zhao F, Downham L, Baena A, Basu P (2023). Molecular triaging options for women testing HPV positive with self-collected samples. Front Oncol. 13:1243888. https://doi.org/10.3389/fonc.2023.1243888 PMID:37810963
82. Valls J, Baena A, Venegas G, Celis M, González M, Sosa C, et al.; ESTAMPA study group (2023). Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study. Lancet Glob Health. 11(3):e350–60. https://doi.org/10.1016/S2214-109X(22)00545-9 PMID:36796982
83. Van Poppel H, Roobol MJ, Chandran A (2023). Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-U. Eur Urol. 84(6):519–22. https://doi.org/10.1016/j.eururo.2023.08.002 PMID:37704541
84. Vazquez-Juárez D, González-Sánchez DG, Andrade-Moreno RA, Villarreal-Garza C (2023). Perception of healthcare system delays and referral pathways for breast cancer care in Mexico: a PhysiciansÓ? survey. Gaceta Mexicana de Oncologa. 22(3):114–21. https://doi.org/10.24875/j.gamo.230001071
85. Waheed DEN, Burdier FR, Eklund C, Baussano I, Mariz FC, Téblick L, et al. (2023). An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses – A meeting report. Prev Med Rep. 35:102368. https://doi.org/10.1016/j.pmedr.2023.102368 PMID:37680853
86. Wei F, Alberts CJ, Albuquerque A, Clifford GM (2023). Impact of Human Papillomavirus Vaccine Against Anal Human Papillomavirus Infection, Anal Intraepithelial Neoplasia, and Recurrence of Anal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis. J Infect Dis. 228(11):1496–504. https://doi.org/10.1093/infdis/jiad183 PMID:37257044
87. Wei F, Goodman MT, Xia N, Zhang J, Giuliano AR, D’Souza G, et al. (2023). Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies. Clin Infect Dis. 76(3):e692–701. https://doi.org/10.1093/cid/ciac581 PMID:35869839
88. Wei F, Xia N, Ocampo R, Goodman MT, Hessol NA, Grinsztejn B, et al. (2023). Age-Specific Prevalence of Anal and Cervical Human Papillomavirus Infection and High-Grade Lesions in 11 177 Women by Human Immunodeficiency Virus Status: A Collaborative Pooled Analysis of 26 Studies. J Infect Dis. 227(4):488–97. https://doi.org/10.1093/infdis/jiac108 PMID:35325151
89. Wijstma ES, Jongen VW, Alberts CJ, de Melker HE, Hoes J, Schim van der Loeff MF (2023). Approaches to Estimating Clearance Rates for Human Papillomavirus Groupings: A Systematic Review and Real Data Examples. Epidemiology. 34(1):119–30. https://doi.org/10.1097/EDE.0000000000001550 PMID:36137191
90. Xia C, Basu P, Kramer BS, Li H, Qu C, Yu XQ, et al. (2023). Cancer screening in China: a steep road from evidence to implementation. Lancet Public Health. 8(12):e996–1005. https://doi.org/10.1016/S2468-2667(23)00186-X PMID:38000379
91. Yao P, Kartsonaki C, Butt J, Jeske R, de Martel C, Plummer M, et al. (2023). Helicobacter pylori multiplex serology and risk of non-cardia and cardia gastric cancer: a case-cohort study and meta-analysis. Int J Epidemiol. 52(4):1197–208. https://doi.org/10.1093/ije/dyad007 PMID:36913255
92. Zhang L, Mosquera I, Lucas E, Rol ML, Carvalho AL, Basu P; CanScreen5 collaborators (2023). CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs. Nat Med. 29(5):1135–45. https://doi.org/10.1038/s41591-023-02315-6 PMID:37106168
93. Zhang L, Sauvaget C, Mosquera I, Basu P (2023). Efficacy, acceptability and safety of ablative versus excisional procedure in the treatment of histologically confirmed CIN2/3: A systematic review. BJOG. 130(2):153–61. https://doi.org/10.1111/1471-0528.17251 PMID:35689493
94. Zhao XL, Zhao S, Xia CF, Hu SY, Duan XZ, Liu ZH, et al. (2023). Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study. BMC Med. 21(1):149. https://doi.org/10.1186/s12916-023-02840-8 PMID:37069602
95. Znaor A, Ryzhov A, Losada ML, Carvalho A, Smelov V, Barchuk A, et al. (2023). Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: A population-based survey. J Cancer Policy. 38:100436. https://doi.org/10.1016/j.jcpo.2023.100436 PMID:37544479
96. Adebamowo, S. N., Befano, B., Cheung, L. C., Rodriguez, A. C., Demarco, M., Rydzak, G., . . . Campos, N. G. (2022). Different human papillomavirus types share early natural history transitions in immunocompetent women. International Journal of Cancer. 151(6): 920-929. PMID: 35603904 https://doi.org/10.1002/ijc.34128       
97. Alberts, C. J., Clifford, G. M., Georges, D., Negro, F., Lesi, O. A., Hutin, Y. J., & de Martel, C. (2022). Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterol Hepatol. 7(8): 724-735. PMID: 35576953 https://doi.org/10.1016/S2468-1253(22)00050-4             
98. Alhomoud, S., Al-Othman, S., Al-Madouj, A., Homsi, M. A., AlSaleh, K., Balaraj, K., . . . Al-Zahrani, A. (2022). Progress and remaining challenges for cancer control in the Gulf Cooperation Council. Lancet Oncology. 23(11): e493-e501. PMID: 36328023 https://doi.org/10.1016/S1470-2045(22)00488-0              
99. Amorrortu, R. P., Zhao, Y., Fenske, N. A., Cherpelis, B. S., Messina, J. L., Giuliano, A. R., . . . Rollison, D. E. (2022). Natural History of Incident and Persistent Cutaneous Human Papillomavirus and Human Polyomavirus Infections. Journal of Infectious Diseases. 226(7): 1162-1174. PMID: 35022780 https://doi.org/10.1093/infdis/jiac004  
100. Asangbeh-Kerman, S. L., Davidovic, M., Taghavi, K., Kachingwe, J., Rammipi, K. M., Muzingwani, L., . . . Bohlius, J. (2022). Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies. BMC Public Health. 22(1): 1530. PMID: 35948944 https://doi.org/10.1186/s12889-022-13827-0            
101. Baisley, K., Kemp, T. J., Kreimer, A. R., Basu, P., Changalucha, J., Hildesheim, A., . . . Watson-Jones, D. (2022). Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial. Lancet Glob Health. 10(10): e1485-e1493. PMID: 36113532 https://doi.org/10.1016/S2214-109X(22)00306-0              
102. Banerjee, D., Mittal, S., Mandal, R., & Basu, P. (2022). Screening technologies for cervical cancer: Overview. Cytojournal. 19: 23. PMID: 35510117 https://doi.org/10.25259/CMAS_03_04_2021         
103. Banila, C., Lorincz, A. T., Scibior-Bentkowska, D., Clifford, G. M., Kumbi, B., Beyene, D., . . . Nedjai, B. (2022). Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide study. International Journal of Cancer. 150(2): 290-302. PMID: 34562270 https://doi.org/10.1002/ijc.33815                
104. Basiletti, J. A., Valls, J., Poklepovich, T., Fellner, M. D., Rol, M., Alonso, R., . . . Picconi, M. A. (2022). Human papillomavirus genotyping using next generation sequencing (NGS) in cervical lesions: Genotypes by histologic grade and their relative proportion in multiple infections. PloS One. 17(11): e0278117. PMID: 36417453 https://doi.org/10.1371/journal.pone.0278117
105. Basu, P., Carvalho, A. L., Almonte, M., Chajes, V., & Weiderpass, E. (2022). Pulling the investment levers on implementation research in oncology. Lancet Oncology. 23(4): 451-452. PMID: 35358451 https://doi.org/10.1016/S1470-2045(22)00025-0             
106. Basu, P., & Muwonge, R. (2022). Alternative analysis of the data from a HPV vaccine study in India – Authors’ reply. Lancet Oncology. 23(1): e10. PMID: 34973220 https://doi.org/10.1016/S1470-2045(21)00729-4
107. Benider, A., Bendahhou, K., Sauvaget, C., Mrabti, H., Selmouni, F., Muwonge, R., . . . Basu, P. (2022). Evolution of patterns of care for women with cervical cancer in Morocco over a decade. BMC Cancer. 22(1): 479. PMID: 35501742 https://doi.org/10.1186/s12885-022-09358-x               
108. Broutet, N., Jeronimo, J., Kumar, S., Almonte, M., Murillo, R., Huy, N. V. Q., . . . Steyn, P. (2022). Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer. Preventive Medicine. 155: 106906. PMID: 34896155 https://doi.org/10.1016/j.ypmed.2021.106906                
109. Bruni, L., Serrano, B., Roura, E., Alemany, L., Cowan, M., Herrero, R., . . . de Sanjose, S. (2022). Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob Health. 10(8): e1115-e1127. PMID: 35839811 https://doi.org/10.1016/S2214-109X(22)00241-8             
110. Chargari, C., Arbyn, M., Leary, A., Abu-Rustum, N. R., Basu, P., Bray, F., . . . Morice, P. (2022). Increasing global accessibility to high-level treatments for cervical cancers. Gynecologic Oncology. 164(1): 231-241. PMID: 34716024 https://doi.org/10.1016/j.ygyno.2021.10.073
111. Chiantore, M. V., Iuliano, M., Mongiovi, R. M., Dutta, S., Tommasino, M., Di Bonito, P., . . . Romeo, G. (2022). The E6 and E7 proteins of beta3 human papillomavirus 49 can deregulate both cellular and extracellular vesicles-carried microRNAs. Infectious Agents and Cancer. 17(1): 29. PMID: 35705991 https://doi.org/10.1186/s13027-022-00445-z     
112. Clasen, J. L., Heath, A. K., Van Puyvelde, H., Huybrechts, I., Park, J. Y., Ferrari, P., . . . Muller, D. C. (2022). Biomarkers of the transsulfuration pathway and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. International Journal of Cancer. 151(5): 708-716. PMID: 35366005 https://doi.org/10.1002/ijc.34009           
113. Correa, R. M., Baena, A., Valls, J., Colucci, M. C., Mendoza, L., Rol, M., . . . Group, E. S. (2022). Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America. PloS One. 17(7): e0272205. PMID: 35905130 https://doi.org/10.1371/journal.pone.0272205
114. Damgacioglu, H., Sonawane, K., Chhatwal, J., Lairson, D. R., Clifford, G. M., Giuliano, A. R., & Deshmukh, A. A. (2022). Long-term impact of HPV vaccination and COVID-19 pandemic on oropharyngeal cancer incidence and burden among men in the USA: A modeling study. Lancet Reg Health Am. 8: 100143. PMID: 34927126 https://doi.org/10.1016/j.lana.2021.100143       
115. Dhokotera, T., Asangbeh, S., Bohlius, J., Singh, E., Egger, M., Rohner, E., . . . Sengayi-Muchengeti, M. (2022). Cervical cancer in women living in South Africa: a record linkage study of the National Health Laboratory Service and the National Cancer Registry. Ecancermedicalscience. 16: 1348. PMID: 35242229 https://doi.org/10.3332/ecancer.2022.1348       
116. Dias, J. M., Santana, I. V. V., da Silva, V. D., Carvalho, A. L., & Arantes, L. (2022). Analysis of Epstein-Barr Virus (EBV) and PD-L1 Expression in Nasopharyngeal Carcinoma Patients in a Non-Endemic Region. International Journal of Molecular Sciences. 23(19). PMID: 36233023 https://doi.org/10.3390/ijms231911720    
117. Donzel, M., Bonjour, M., Combes, J. D., Broussais, F., Sesques, P., Traverse-Glehen, A., & de Martel, C. (2022). Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in France. EClinicalMedicine. 54: 101674. PMID: 36204003 https://doi.org/10.1016/j.eclinm.2022.101674  
118. Duan, R., Zhang, H., Wu, A., Li, C., Li, L., Xu, X., . . . Clifford, G. (2022). Prevalence and risk factors for anogenital HPV infection and neoplasia among women living with HIV in China. Sexually Transmitted Infections. 98(4): 247-254. PMID: 34187906 https://doi.org/10.1136/sextrans-2021-055019    
119. Fokom Domgue, J., Pande, M., Yu, R., Manjuh, F., Welty, E., Welty, T., . . . Shete, S. (2022). Development, Implementation, and Evaluation of a Distance Learning and Telementoring Program for Cervical Cancer Prevention in Cameroon. JAMA Netw Open. 5(11): e2240801. PMID: 36346631 https://doi.org/10.1001/jamanetworkopen.2022.40801
120. Galati, L., Combes, J. D., Le Calvez-Kelm, F., McKay-Chopin, S., Forey, N., Ratel, M., . . . Gheit, T. (2022). Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay. Microbiol Spectr. 10(2): e0148021. PMID: 35225653 https://doi.org/10.1128/spectrum.01480-21
121. Gallus, R., Gheit, T., Holzinger, D., Petrillo, M., Rizzo, D., Petrone, G., . . . Bussu, F. (2022). Prevalence of HPV Infection and p16(INK4a) Overexpression in Surgically Treated Laryngeal Squamous Cell Carcinoma. Vaccines (Basel). 10(2): 13. PMID: 35214663 https://doi.org/10.3390/vaccines10020204  
122. Geng, C. X., Tanamal, P., Arvisais-Anhalt, S., Tomasino, M., Gheit, T., Bishop, J. A., . . . Day, A. T. (2022). Clinical and Biologic Characteristics and Outcomes in Young and Middle-Aged Patients With Laryngeal Cancer: A Retrospective Cohort Analysis. Otolaryngology and Head and Neck Surgery. 167(4): 688-698. PMID: 35077266 https://doi.org/10.1177/01945998211073707   
123. Ginindza, T. G., Forestier, M., & Almonte, M. (2022). Cervical cancer screening by visual inspection and HPV testing in Eswatini. Preventive Medicine. 161: 107144. PMID: 35810934 https://doi.org/10.1016/j.ypmed.2022.107144                
124. Hariprasad, R., Mittal, S., & Basu, P. (2022). Role of colposcopy in the management of women with abnormal cytology. Cytojournal. 19: 40. PMID: 35928528 https://doi.org/10.25259/CMAS_03_15_2021         
125. Hu, S. Y., Kreimer, A. R., Porras, C., Guillen, D., Alfaro, M., Darragh, T. M., . . . Costa Rica, H. P. V. V. T. G. (2022). Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial. Journal of the National Cancer Institute. 114(9): 1253-1261. PMID: 35640980 https://doi.org/10.1093/jnci/djac107                
126. Ibrahim Khalil, A., Franceschi, S., de Martel, C., Bray, F., & Clifford, G. M. (2022). Burden of Kaposi sarcoma according to HIV status: A systematic review and global analysis. International Journal of Cancer. 150(12): 1948-1957. PMID: 35085400 https://doi.org/10.1002/ijc.33951        
127. Ibrahim Khalil, A., Mpunga, T., Wei, F., Baussano, I., de Martel, C., Bray, F., . . . Clifford, G. M. (2022). Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa. International Journal of Cancer. 150(5): 761-772. PMID: 34626498 https://doi.org/10.1002/ijc.33841       
128. Lebeau, A., Bruyere, D., Roncarati, P., Peixoto, P., Hervouet, E., Cobraiville, G., . . . Herfs, M. (2022). HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources. Nat Commun. 13(1): 1076. PMID: 35228537 https://doi.org/10.1038/s41467-022-28724-8                
129. Leja, M., Cine, E., Polaka, I., Daugule, I., Murillo, R., Parshutin, S., . . . Park, J. Y. (2022). Factors influencing participation in preventive interventions for gastric cancer: the results from the GISTAR study. European Journal of Cancer Prevention. 31(2): 128-136. PMID: 34519690 https://doi.org/10.1097/CEJ.0000000000000682   
130. Li, M., Zhang, L., Charvat, H., Callister, M. E., Sasieni, P., Christodoulou, E., . . . Robbins, H. A. (2022). The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials. International Journal of Cancer. 151(9): 1491-1501. PMID: 35809038 https://doi.org/10.1002/ijc.34167           
131. Lopez-Filloy, M., Cortez, F. J., Gheit, T., Cruz, Y. C. O., Cruz-Talonia, F., Chavez-Torres, M., . . . Rocha-Zavaleta, L. (2022). Altered Vaginal Microbiota Composition Correlates With Human Papillomavirus and Mucosal Immune Responses in Women With Symptomatic Cervical Ectopy. Front Cell Infect Microbiol. 12: 884272. PMID: 35656032 https://doi.org/10.3389/fcimb.2022.884272
132. Lourencao, M., Simoes Correa Galendi, J., Galvao, H. C. R., Antoniazzi, A. P., Grasel, R. S., Carvalho, A. L., . . . Palmero, E. I. (2022). Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income Country. Frontiers in Oncology. 12: 951310. PMID: 35898894 https://doi.org/10.3389/fonc.2022.951310         
133. Makau-Barasa, L. K., Manirakiza, A., Carvalho, A. L., & Rebbeck, T. R. (2022). Prostate Cancer Screening, Diagnostic, Treatment Procedures and Costs in Sub-Saharan Africa: A Situational Analysis. Cancer Control. 29: 10732748221084932. PMID: 35350915 https://doi.org/10.1177/10732748221084932    
134. Man, I., Georges, D., de Carvalho, T. M., Ray Saraswati, L., Bhandari, P., Kataria, I., . . . Baussano, I. (2022). Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study. Lancet Oncology. 23(11): 1419-1429. PMID: 36174583 https://doi.org/10.1016/S1470-2045(22)00543-5              
135. Mao, J. J., Pillai, G. G., Andrade, C. J., Ligibel, J. A., Basu, P., Cohen, L., . . . Salicrup, L. A. (2022). Integrative oncology: Addressing the global challenges of cancer prevention and treatment. CA: A Cancer Journal for Clinicians. 72(2): 144-164. PMID: 34751943 https://doi.org/10.3322/caac.21706    
136. Matos, L. L., Capuzzo, R. C., Pedruzzi, P. A. G., Farias, T., de Farias, J. W. M., Chone, C. T., . . . Kowalski, L. P. (2022). Sentinel lymph node biopsy for early squamous cell carcinoma of the lip and oral cavity: Real-world experience in Brazil. Head and Neck. 44(7): 1604-1615. PMID: 35427429 https://doi.org/10.1002/hed.27061              
137. Mosquera, I., Ilbawi, A., Muwonge, R., Basu, P., & Carvalho, A. L. (2022). Cancer burden and status of cancer control measures in fragile states: a comparative analysis of 31 countries. Lancet Glob Health. 10(10): e1443-e1452. PMID: 36113529 https://doi.org/10.1016/S2214-109X(22)00331-X          
138. Mpunga, T., Clifford, G. M., Morgan, E. A., Milner, D. A., Jr., de Martel, C., Munyanshongore, C., . . . Combes, J. D. (2022). Epstein-Barr virus prevalence among subtypes of malignant lymphoma in Rwanda, 2012 to 2018. International Journal of Cancer. 150(5): 753-760. PMID: 34626122 https://doi.org/10.1002/ijc.33840       
139. Mwanahamuntu, M., Kapambwe, S., Pinder, L. F., Matambo, J., Chirwa, S., Chisele, S., . . . Parham, G. P. (2022). The use of thermal ablation in diverse cervical cancer « screen-and-treat » service platforms in Zambia. International Journal of Gynaecology and Obstetrics. 157(1): 85-89. PMID: 34197624 https://doi.org/10.1002/ijgo.13808                
140. Parak, U., Lopes Carvalho, A., Roitberg, F., & Mandrik, O. (2022). Effectiveness of screening for oral cancer and oral potentially malignant disorders (OPMD): A systematic review. Preventive Medicine Reports. 30: 101987. PMID: 36189128 https://doi.org/10.1016/j.pmedr.2022.101987
141. Prudden, H. J., Achilles, S. L., Schocken, C., Broutet, N., Canfell, K., Akaba, H., . . . Therapeutic, H. P. V. V. P. P. C. E. C. G. (2022). Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022. Vaccine. 40(41): 5843-5855. PMID: 36008233 https://doi.org/10.1016/j.vaccine.2022.08.020      
142. Razuka-Ebela, D., Polaka, I., Daugule, I., Parshutin, S., Santare, D., Ebela, I., . . . Leja, M. (2022). Lifestyle and dietary factors associated with serologically detected gastric atrophy in a Caucasian population in the GISTAR study. European Journal of Cancer Prevention. 31(5): 442-450. PMID: 35131967 https://doi.org/10.1097/CEJ.0000000000000723             
143. Razuka-Ebela, D., Polaka, I., Daugule, I., Parshutin, S., Santare, D., Ebela, I., . . . Leja, M. (2022). Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study. Diagnostics (Basel). 12(5): 11. PMID: 35626319 https://doi.org/10.3390/diagnostics12051166   
144. Ritchie, D., Arbyn, M., Basu, P., Corbex, M., Fidarova, E., Ivanus, U., . . . Zacharopoulou, C. (2022). Europe’s Path to Eliminating Cervical Cancer as a Public Health Problem. Lancet Reg Health Eur. 12: 100276. PMID: 34901914 https://doi.org/10.1016/j.lanepe.2021.100276  
145. Rol, M. L., Picconi, M. A., Ferrera, A., Sanchez, G. I., Hernandez, M. L., Lineros, J., . . . Almonte, M. (2022). Implementing HPV testing in 9 Latin American countries: The laboratory perspective as observed in the ESTAMPA study. Front Med (Lausanne). 9: 1006038. PMID: 36465901 https://doi.org/10.3389/fmed.2022.1006038     
146. Saponaro, C., Galati, L., Gheit, T., Pappagallo, S. A., Zambetti, M., Zito, F. A., . . . Tommasino, M. (2022). Alteration of Na/H exchange regulatory factor-1 protein levels in anogenital lesions positive for mucosal high-risk human papillomavirus type 16. Virology. 576: 69-73. PMID: 36179457 https://doi.org/10.1016/j.virol.2022.09.004                
147. Sauvaget, C., Bazikamwe, S., Lucas, E., Ndayikengurukiye, A., Harerimana, S., & Barango, P. (2022). Evaluation of effectiveness, acceptability and safety of thermal ablation in the treatment of cervical neoplasia in Burundi. International Journal of Cancer. 151(7): 1120-1126. PMID: 35567576 https://doi.org/10.1002/ijc.34117  
148. Schulte-Frohlinde, R., Georges, D., Clifford, G. M., & Baussano, I. (2022). Predicting Cohort-Specific Cervical Cancer Incidence From Population-Based Surveys of Human Papilloma Virus Prevalence: A Worldwide Study. American Journal of Epidemiology. 191(3): 402-412. PMID: 34652438 https://doi.org/10.1093/aje/kwab254                
149. Selmouni, F., Amrani, L., Sauvaget, C., Bakkar, M., El Khannoussi, B., Souadka, A., . . . Basu, P. (2022). Delivering colorectal cancer screening integrated with primary health care services in Morocco: Lessons learned from a demonstration project. Cancer. 128(6): 1219-1229. PMID: 34985785 https://doi.org/10.1002/cncr.34061                
150. Selmouni, F., Guy, M., Muwonge, R., Nassiri, A., Lucas, E., Basu, P., & Sauvaget, C. (2022). Effectiveness of Artificial Intelligence-Assisted Decision-making to Improve Vulnerable Women’s Participation in Cervical Cancer Screening in France: Protocol for a Cluster Randomized Controlled Trial (AppDate-You). JMIR Res Protoc. 11(8): e39288. PMID: 35771872 https://doi.org/10.2196/39288             
151. Selmouni, F., Sauvaget, C., Dangbemey, D. P., Kpebo, D. D. O., Dieng, N. M., Lucas, E., . . . Basu, P. (2022). Lessons Learnt From Pilot Cervical Cancer Screening and Treatment Programmes Integrated to Routine Primary Health Care Services in Benin, Cote d’Ivoire, and Senegal. JCO Glob Oncol. 8: e2200051. PMID: 36070534 https://doi.org/10.1200/GO.22.00051   
152. Sharkey Ochoa, I., O’Regan, E., Toner, M., Kay, E., Faul, P., O’Keane, C., . . . Martin, C. M. (2022). The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma. Cancers. 14(17): 4321. PMID: 36077856 https://doi.org/10.3390/cancers14174321           
153. Shastri, S. S., Temin, S., Almonte, M., Basu, P., Campos, N. G., Gravitt, P. E., . . . Jeronimo, J. (2022). Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Guideline Update. JCO Glob Oncol. 8: e2200217. PMID: 36162041 https://doi.org/10.1200/GO.22.00217
154. Shing, J. Z., Hu, S., Herrero, R., Hildesheim, A., Porras, C., Sampson, J. N., . . . Costa Rica, H. P. V. V. T. G. (2022). Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial. Lancet Oncology. 23(7): 940-949. PMID: 35709811 https://doi.org/10.1016/S1470-2045(22)00291-1            
155. Sichero, L., Tagliabue, M., Mota, G., Ferreira, S., Nunes, R. A. L., Castaneda, C. A., . . . Group, H. E. S. (2022). Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16(INK4a) status. Head and Neck. 44(1): 122-133. PMID: 34726297 https://doi.org/10.1002/hed.26912        
156. Simoens, C., Gheit, T., Ridder, R., Gorbaslieva, I., Holzinger, D., Lucas, E., . . . group, H.-A. s. (2022). Accuracy of high-risk HPV DNA PCR, p16((INK4a)) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer. BMC Infectious Diseases. 22(1): 676. PMID: 35933382 https://doi.org/10.1186/s12879-022-07654-2     
157. Sjomina, O., Lielause, A., Rudule, A., Vangravs, R., Parsutins, S., Polaka, I., . . . Leja, M. (2022). Randomised clinical trial: comparison of efficacy and adverse effects of a standard triple clarithromycin-containing regimen with high-dose amoxicillin and bismuth therapy in Helicobacter pylori eradication. European Journal of Cancer Prevention. 31(4): 333-338. PMID: 35471812 https://doi.org/10.1097/CEJ.0000000000000718   
158. Skakkebaek, N. E., Lindahl-Jacobsen, R., Levine, H., Andersson, A. M., Jorgensen, N., Main, K. M., . . . Juul, A. (2022). Environmental factors in declining human fertility. Nature Reviews: Endocrinology. 18(3): 139-157. PMID: 34912078 https://doi.org/10.1038/s41574-021-00598-8               
159. Skrebinska, S., Megraud, F., Daugule, I., Santare, D., Isajevs, S., Liepniece-Karele, I., . . . Leja, M. (2022). Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection? Diagnostics (Basel). 12(1). PMID: 35054298 https://doi.org/10.3390/diagnostics12010133    
160. Smelov, V., Trusova, O., Barbier, S., Muwonge, R., Grankov, V., Rusovich, V., . . . Dara, M. (2022). Rationale and Purpose: The FLUTE Study to Evaluate Fluorography Mass Screening for Tuberculosis and Other Diseases, as Conducted in Eastern Europe and Central Asia Countries. International Journal of Environmental Research and Public Health. 19(14): 8706. PMID: 35886558 https://doi.org/10.3390/ijerph19148706   
161. Tsang, S. H., Schiller, J. T., Porras, C., Kemp, T. J., Herrero, R., Schussler, J., . . . Costa Rica, H. P. V. V. T. G. (2022). HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial. NPJ Vaccines. 7(1): 40. PMID: 35351898 https://doi.org/10.1038/s41541-022-00431-x               
162. Van Poppel, H., Albreht, T., Basu, P., Hogenhout, R., Collen, S., & Roobol, M. (2022). Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future. Nat Rev Urol. 19(9): 562-572. PMID: 35974245 https://doi.org/10.1038/s41585-022-00638-6               
163. Veljkovikj, I., Ilbawi, A. M., Roitberg, F., Luciani, S., Barango, P., Corbex, M., . . . Stevens, L. M. (2022). Evolution of the joint International Atomic Energy Agency (IAEA), International Agency for Research on Cancer (IARC), and WHO cancer control assessments (imPACT Reviews). Lancet Oncology. 23(10): e459-e468. PMID: 36174632 https://doi.org/10.1016/S1470-2045(22)00387-4             
164. Vicente, A., Novoloaca, A., Cahais, V., Awada, Z., Cuenin, C., Spitz, N., . . . Ghantous, A. (2022). Cutaneous and acral melanoma cross-OMICs reveals prognostic cancer drivers associated with pathobiology and ultraviolet exposure. Nat Commun. 13(1): 4115. PMID: 35840550 https://doi.org/10.1038/s41467-022-31488-w      
165. Yao, P., Millwood, I., Kartsonaki, C., Mentzer, A. J., Allen, N., Jeske, R., . . . Chen, Z. (2022). Sero-prevalence of 19 infectious pathogens and associated factors among middle-aged and elderly Chinese adults: a cross-sectional study. BMJ Open. 12(5): e058353. PMID: 35534062 https://doi.org/10.1136/bmjopen-2021-058353        
166. Yuan, T., Hu, Y., Zhou, X., Yang, L., Wang, H., Li, L., . . . Zou, H. (2022). Incidence and mortality of non-AIDS-defining cancers among people living with HIV: A systematic review and meta-analysis. EClinicalMedicine. 52: 101613. PMID: 35990580 https://doi.org/10.1016/j.eclinm.2022.101613
167. Zhang, L., Carvalho, A. L., Mosquera, I., Wen, T., Lucas, E., Sauvaget, C., . . . Basu, P. (2022). An international consensus on the essential and desirable criteria for an ‘organized’ cancer screening programme. BMC Medicine. 20(1): 101. PMID: 35317783 https://doi.org/10.1186/s12916-022-02291-7       
168. Zhang, L., Zhao, X., Hu, S., Chen, S., Zhao, S., Dong, L., . . . Basu, P. (2022). Triage performance and predictive value of the human gene methylation panel among women positive on self-collected HPV test: Results from a prospective cohort study. International Journal of Cancer. 151(6): 878-887. PMID: 35460075 https://doi.org/10.1002/ijc.34041           
169. Zhao, S., Huang, L., Basu, P., Domingo, E. J., Supakarapongkul, W., Ling, W. Y., . . . Zhao, F. (2022). Cervical cancer burden, status of implementation and challenges of cervical cancer screening in Association of Southeast Asian Nations (ASEAN) countries. Cancer Letters. 525: 22-32. PMID: 34728309 https://doi.org/10.1016/j.canlet.2021.10.036  
170. Aglago, E. K., Murphy, N., Huybrechts, I., Nicolas, G., Casagrande, C., Fedirko, V., . . . Gunter, M. J. (2021). Dietary intake and plasma phospholipid concentrations of saturated, monounsaturated and trans fatty acids and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort. Int J Cancer. 149(4): 865-882. PMID: 33913149  doi: 10.1002/ijc.33615
171. Albuquerque, A., Baptista, P. V., & Clifford, G. M. (2021). For Anal Cancer, Not All Women Are Equal. Am J Gastroenterol. 116(10): 2140. PMID: 34618701  doi: 10.14309/ajg.0000000000001298
172. Amorrortu, R. P., Zhao, Y., Messina, J. L., Schell, M. J., Fenske, N. A., Cherpelis, B. S., . . . Rollison, D. E. (2021). Association between Human Polyomaviruses and Keratinocyte Carcinomas: A Prospective Cohort Study. Cancer Epidemiol Biomarkers Prev. 30(9): 1761-1764. PMID: 34187857  doi: 10.1158/1055-9965.EPI-21-0332
173. Arbyn, M., Gultekin, M., Morice, P., Nieminen, P., Cruickshank, M., Poortmans, P., . . . Weiderpass, E. (2021). The European response to the WHO call to eliminate cervical cancer as a public health problem. Int J Cancer. 148(2): 277-284. PMID: 32638362  doi: 10.1002/ijc.33189
174. Arbyn, M., Simon, M., Peeters, E., Xu, L., Meijer, C., Berkhof, J., . . . Poljak, M. (2021). 2020 list of human papillomavirus assays suitable for primary cervical cancer screening. Clin Microbiol Infect. 27(8): 1083-1095. PMID: 33975008  doi: 10.1016/j.cmi.2021.04.031
175. Basu, P., Alhomoud, S., Taghavi, K., Carvalho, A. L., Lucas, E., & Baussano, I. (2021). Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a New Situation. JCO Glob Oncol. 7: 416-424. PMID: 33784177  doi: 10.1200/GO.21.00033
176. Basu, P., Lucas, E., Zhang, L., Muwonge, R., Murillo, R., & Nessa, A. (2021). Leveraging vertical COVID-19 investments to improve monitoring of cancer screening programme – A case study from Bangladesh. Prev Med. 151: 106624. PMID: 34023359  doi: 10.1016/j.ypmed.2021.106624
177. Basu, P., Malvi, S. G., Joshi, S., Bhatla, N., Muwonge, R., Lucas, E., . . . Sankaranarayanan, R. (2021). Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study. Lancet Oncol. 22(11): 1518-1529. PMID: 34634254  doi: 10.1016/S1470-2045(21)00453-8
178. Basu, P., Tripathi, R., Mehrotra, R., Ray, K., Srivastava, A., & Srivastava, A. (2021). Role of integrative medicine in the continuum of care of breast cancer patients in the Indian context. Cancer Causes Control. 32(5): 429-440. PMID: 33528692  doi: 10.1007/s10552-021-01399-0
179. Baussano, I., Sayinzoga, F., Tshomo, U., Tenet, V., Vorsters, A., Heideman, D. A. M., . . . Clifford, G. M. (2021). Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan. Emerg Infect Dis. 27(1): 1-9. PMID: 33350922  doi: 10.3201/eid2701.191364
180. Bhatla, N., Aoki, D., Sharma, D. N., & Sankaranarayanan, R. (2021). Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet. 155 Suppl 1: 28-44. PMID: 34669203  doi: 10.1002/ijgo.13865
181. Bhatla, N., Nessa, A., Oswal, K., Vashist, S., Sebastian, P., & Basu, P. (2021). Program organization rather than choice of test determines success of cervical cancer screening: Case studies from Bangladesh and India. Int J Gynaecol Obstet. 152(1): 40-47. PMID: 33205399  doi: 10.1002/ijgo.13486
182. Bonjour, M., Charvat, H., Franco, E. L., Pineros, M., Clifford, G. M., Bray, F., & Baussano, I. (2021). Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis. Lancet Public Health. 6(7): e510-e521. PMID: 33864738  doi: 10.1016/S2468-2667(21)00046-3
183. Brancaccio, R. N., Robitaille, A., Dutta, S., Rollison, D. E., Tommasino, M., & Gheit, T. (2021). MinION nanopore sequencing and assembly of a complete human papillomavirus genome. J Virol Methods. 294: 114180. PMID: 33965458  doi: 10.1016/j.jviromet.2021.114180
184. Brotherton, J. M. L., Wheeler, C., Clifford, G. M., Elfstrom, M., Saville, M., Kaldor, J., & Machalek, D. A. (2021). Surveillance systems for monitoring cervical cancer elimination efforts: Focus on HPV infection, cervical dysplasia, cervical screening and treatment. Prev Med. 144: 106293. PMID: 33075352  doi: 10.1016/j.ypmed.2020.106293
185. Caicedo-Martinez, M., Fernandez-Deaza, G., Ordonez-Reyes, C., Olejua, P., Nuche-Berenguer, B., Mello, M. B., & Murillo, R. (2021). High-risk human papillomavirus infection among women living with HIV in Latin America and the Caribbean: A systematic review and meta-analysis. Int J STD AIDS. 32(14): 1278-1289. PMID: 34488503  doi: 10.1177/09564624211037498
186. Cheung, L. C., Ramadas, K., Muwonge, R., Katki, H. A., Thomas, G., Graubard, B. I., . . . Chaturvedi, A. K. (2021). Risk-Based Selection of Individuals for Oral Cancer Screening. J Clin Oncol. 39(6): 663-674. PMID: 33449824  doi: 10.1200/JCO.20.02855
187. Chung, M. H., De Vuyst, H., Greene, S. A., Mugo, N. R., Querec, T. D., Nyongesa-Malava, E., . . . McGrath, C. J. (2021). Human Papillomavirus Persistence and Association With Recurrent Cervical Intraepithelial Neoplasia After Cryotherapy vs Loop Electrosurgical Excision Procedure Among HIV-Positive Women: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 7(10): 1514-1520. PMID: 34351377  doi: 10.1001/jamaoncol.2021.2683
188. Chung, M. H., De Vuyst, H., Greene, S. A., Topazian, H. M., Sayed, S., Moloo, Z., . . . McGrath, C. J. (2021). Loop electrosurgical excision procedure (LEEP) plus top hat for HIV-infected women with endocervical intraepithelial neoplasia in Kenya. Int J Gynaecol Obstet. 152(1): 118-124. PMID: 33145753  doi: 10.1002/ijgo.13466
189. Clasen, J. L., Heath, A. K., Van Puyvelde, H., Huybrechts, I., Park, J. Y., Ferrari, P., . . . Muller, D. C. (2021). A comparison of complementary measures of vitamin B6 status, function, and metabolism in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 114(1): 338-347. PMID: 33829249  doi: 10.1093/ajcn/nqab045
190. Clifford, G. M., & Alberts, C. J. (2021). Molecular Risk Stratification for Anal Cancer Prevention. Clin Infect Dis. 72(12): 2164-2166. PMID: 32266927  doi: 10.1093/cid/ciaa399
191. Clifford, G. M., Georges, D., Shiels, M. S., Engels, E. A., Albuquerque, A., Poynten, I. M., . . . Stier, E. A. (2021). A meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale. Int J Cancer. 148(1): 38-47. PMID: 32621759  doi: 10.1002/ijc.33185
192. Combes, J. D., Voisin, N., Perie, S., Malard, O., Jegoux, F., Nadjingar, R., . . . Lacau St Guily, J. (2021). History of tonsillectomy and risk of oropharyngeal cancer. Oral Oncol. 117: 105302. PMID: 33905915  doi: 10.1016/j.oraloncology.2021.105302
193. Dillner, J., Elfstrom, K. M., & Baussano, I. (2021). Prospects for accelerated elimination of cervical cancer. Prev Med. 153: 106827. PMID: 34599922  doi: 10.1016/j.ypmed.2021.106827
194. Drolet, M., Laprise, J. F., Martin, D., Jit, M., Benard, E., Gingras, G., . . . Brisson, M. (2021). Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis. Lancet Infect Dis. 21(11): 1598-1610. PMID: 34245682  doi: 10.1016/S1473-3099(20)30860-4
195. Dube Mandishora, R. S., Rounge, T. B., Fitzpatrick, M., Christiansen, I. K., Ambur, O. H., Lagstrom, S., . . . Chirenje, Z. M. (2021). Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping. PLoS One. 16(4): e0250426. PMID: 33901223  doi: 10.1371/journal.pone.0250426
196. Duffell, E., Cortez-Pinto, H., Simonova, M., Dalgard, O., Dahl, E. H., de Martel, C., . . . Mardh, O. (2021). Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C. J Viral Hepat. 28(8): 1177-1189. PMID: 34003542  doi: 10.1111/jvh.13545
197. Escriva-Boulley, G., Mandrik, O., Preau, M., Herrero, R., & Villain, P. (2021). Cognitions and behaviours of general practitioners in France regarding HPV vaccination: A theory-based systematic review. Prev Med. 143: 106323. PMID: 33171178  doi: 10.1016/j.ypmed.2020.106323
198. Fadhil, I., Alkhalawi, E., Nasr, R., Fouad, H., Basu, P., Camacho, R., & Alsaadoon, H. (2021). National cancer control plans across the Eastern Mediterranean region: challenges and opportunities to scale-up. Lancet Oncol. 22(11): e517-e529. PMID: 34735820  doi: 10.1016/S1470-2045(21)00410-1
199. Ferreiro-Iglesias, A., McKay, J. D., Brenner, N., Virani, S., Lesseur, C., Gaborieau, V., . . . Brennan, P. (2021). Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer. Nat Commun. 12(1): 5945. PMID: 34642315  doi: 10.1038/s41467-021-26151-9
200. Galati, L., Brancaccio, R. N., Gupta, P., Lohmann, E., Robitaille, A., Mandishora, R. S. D., . . . Gheit, T. (2021). Diversity of human papillomavirus in the anal canal of HIV-positive and HIV-negative men. J Infect. 82(1): 112-116. PMID: 33253726  doi: 10.1016/j.jinf.2020.11.030
201. Gama, R. R., Arantes, L., Sorroche, B. P., De Marchi, P., Melendez, M. E., Carvalho, R. S., . . . Carvalho, A. L. (2021). Evaluation of acetylation and methylation in oral rinse of patients with head and neck cancer history exposed to valproic acid. Sci Rep. 11(1): 16415. PMID: 34385507  doi: 10.1038/s41598-021-95845-3
202. Ginsburg, O., Basu, P., Kapambwe, S., & Canfell, K. (2021). Eliminating cervical cancer in the COVID-19 era. Nat Cancer. 2(2): 133-134. PMID: 35122078  doi: 10.1038/s43018-021-00178-9
203. Giraldi, L., Collatuzzo, G., Hashim, D., Franceschi, S., Herrero, R., Chen, C., . . . Boffetta, P. (2021). Infection with Human Papilloma Virus (HPV) and risk of subsites within the oral cancer. Cancer Epidemiol. 75: 102020. PMID: 34509873  doi: 10.1016/j.canep.2021.102020
204. Jongen, V. W., van der Loeff, M. F. S., Boyd, A., Petrignani, M., Prins, M., van der Wal, M., . . . Alberts, C. J. (2021). Human papillomavirus vaccination uptake: a longitudinal study showing ethnic differences in the influence of the intention-to-vaccinate among parent-daughter dyads. Hum Vaccin Immunother. 17(4): 990-999. PMID: 32966170  doi: 10.1080/21645515.2020.1808411
205. Joshi, S., Muwonge, R., Kulkarni, V., Lucas, E., Kulkarni, S., Kand, S., . . . Rengaswamy, S. (2021). Mobile Screening Unit (MSU) for the Implementation of the ‘Screen and Treat’ Programme for Cervical Cancer Prevention In Pune, India. Asian Pac J Cancer Prev. 22(2): 413-418. PMID: 33639655  doi: 10.31557/APJCP.2021.22.2.413
206. Kim, Y. I., Lee, J. Y., Kim, C. G., Park, B., Park, J. Y., & Choi, I. J. (2021). Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial. BMC Gastroenterol. 21(1): 95. PMID: 33653284  doi: 10.1186/s12876-021-01680-1
207. Lesseur, C., Ferreiro-Iglesias, A., McKay, J. D., Bosse, Y., Johansson, M., Gaborieau, V., . . . Brennan, P. (2021). Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers. PLoS Genet. 17(3): e1009254. PMID: 33667223  doi: 10.1371/journal.pgen.1009254
208. Li, M., Delafosse, P., Meheus, F., Borson-Chazot, F., Lifante, J. C., Simon, R., . . . Thyroid Cancer Group, F. (2021). Temporal and geographical variations of thyroid cancer incidence and mortality in France during 1986-2015: The impact of overdiagnosis. Cancer Epidemiol. 75: 102051. PMID: 34743057  doi: 10.1016/j.canep.2021.102051
209. Lozar, T., Nagvekar, R., Rohrer, C., Dube Mandishora, R. S., Ivanus, U., & Fitzpatrick, M. B. (2021). Cervical Cancer Screening Postpandemic: Self-Sampling Opportunities to Accelerate the Elimination of Cervical Cancer. Int J Womens Health. 13: 841-859. PMID: 34566436  doi: 10.2147/IJWH.S288376
210. Magnotti, F., Valsesia, S., Gupta, P., Flechtenmacher, C., Contard, P., Viarisio, D., . . . Henry, T. (2021). The Inflammasome Adaptor ASC Delays UV-Induced Skin Tumorigenesis in Beta HPV38 E6 and E7 Transgenic Mice. J Invest Dermatol. 141(1): 236-238 e232. PMID: 32470340  doi: 10.1016/j.jid.2020.04.028
211. Matos, L. L., Forster, C. H. Q., Marta, G. N., Castro Junior, G., Ridge, J. A., Hirata, D., . . . Kowalski, L. P. (2021). The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying-the head and neck cancer model. Cancer Causes Control. 32(5): 459-471. PMID: 33704627  doi: 10.1007/s10552-021-01411-7
212. Mattoscio, D., Gheit, T., Strati, K., & Venuti, A. (2021). Editorial: HPV and Host Interaction. Front Cell Infect Microbiol. 11: 638005. PMID: 33777848  doi: 10.3389/fcimb.2021.638005
213. Miranda-Filho, A., Charvat, H., Bray, F., Migowski, A., Cheung, L. C., Vaccarella, S., . . . Robbins, H. A. (2021). A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil. EClinicalMedicine. 42: 101176. PMID: 34765952  doi: 10.1016/j.eclinm.2021.101176
214. Mrabti, H., Sauvaget, C., Benider, A., Bendahhou, K., Selmouni, F., Muwonge, R., . . . Basu, P. (2021). Patterns of care of breast cancer patients in Morocco – A study of variations in patient profile, tumour characteristics and standard of care over a decade. Breast. 59: 193-202. PMID: 34280610  doi: 10.1016/j.breast.2021.07.009
215. Mrabti, H., Sauvaget, C., Benider, A., Bendahhou, K., Selmouni, F., Muwonge, R., . . . Basu, P. (2021). Reply to: Chronic pain assessment and management during post-treatment follow up should be considered as a high value quality indicator for specialist breast cancer center. Breast. 60: 309. PMID: 34509362  doi: 10.1016/j.breast.2021.09.003
216. Ortmann, O., Torode, J., Schmiegel, W., Thomssen, C., Hakama, M., Basu, P., . . . participants of the, E. (2021). Correction to: Knowledge transfer as a tool towards improvement of cancer care in low- and middle-income countries. 6th European Roundtable Meeting (ERTM), June 14th, 2019, Berlin, Germany. J Cancer Res Clin Oncol. 147(12): 3773. PMID: 34213663  doi: 10.1007/s00432-021-03709-0
217. Park, J. Y., & Herrero, R. (2021). Recent progress in gastric cancer prevention. Best Pract Res Clin Gastroenterol. 50-51: 101733. PMID: 33975687  doi: 10.1016/j.bpg.2021.101733
218. Pimenoff, V. N., Elfstrom, M., Baussano, I., Bjornstedt, M., & Dillner, J. (2021). Estimating Total Excess Mortality During a Coronavirus Disease 2019 Outbreak in Stockholm, Sweden. Clin Infect Dis. 72(11): e890-e892. PMID: 33070183  doi: 10.1093/cid/ciaa1593
219. Pineros, M., Saraiya, M., Baussano, I., Bonjour, M., Chao, A., & Bray, F. (2021). The role and utility of population-based cancer registries in cervical cancer surveillance and control. Prev Med. 144: 106237. PMID: 33678223  doi: 10.1016/j.ypmed.2020.106237
220. Pinheiro, M., Harari, A., Schiffman, M., Clifford, G. M., Chen, Z., Yeager, M., . . . Mirabello, L. (2021). Phylogenomic Analysis of Human Papillomavirus Type 31 and Cervical Carcinogenesis: A Study of 2093 Viral Genomes. Viruses. 13(10): 19. PMID: 34696378  doi: 10.3390/v13101948
221. Polaka, I., Razuka-Ebela, D., Park, J. Y., & Leja, M. (2021). Taxonomy-based data representation for data mining: an example of the magnitude of risk associated with H. pylori infection. BioData Min. 14(1): 43. PMID: 34454568  doi: 10.1186/s13040-021-00271-w
222. Ramirez, A. T., Sanchez, G. I., Nedjai, B., Agudelo, M. C., Brentnall, A. R., Cuschieri, K., . . . Group, A.-U.-C. T. (2021). Effective methylation triage of HPV positive women with abnormal cytology in a middle-income country. Int J Cancer. 148(6): 1383-1393. PMID: 33006394  doi: 10.1002/ijc.33314
223. Ringborg, U., Berns, A., Celis, J. E., Heitor, M., Tabernero, J., Schuz, J., . . . Zitvogel, L. (2021). The Porto European Cancer Research Summit 2021. Mol Oncol. 15(10): 2507-2543. PMID: 34515408  doi: 10.1002/1878-0261.13078
224. Rollison, D. E., Amorrortu, R. P., Zhao, Y., Messina, J. L., Schell, M. J., Fenske, N. A., . . . Tommasino, M. (2021). Cutaneous Human Papillomaviruses and the Risk of Keratinocyte Carcinomas. Cancer Res. 81(17): 4628-4638. PMID: 34266893  doi: 10.1158/0008-5472.CAN-21-0805
225. Sierra, M. S., Tsang, S. H., Hu, S., Porras, C., Herrero, R., Kreimer, A. R., . . . Costa Rica Human Papillomavirus Vaccine Trial, G. (2021). Risk Factors for Non-Human Papillomavirus (HPV) Type 16/18 Cervical Infections and Associated Lesions Among HPV DNA-Negative Women Vaccinated Against HPV-16/18 in the Costa Rica Vaccine Trial. J Infect Dis. 224(3): 503-516. PMID: 33326576  doi: 10.1093/infdis/jiaa768
226. Simoens, C., Gorbaslieva, I., Gheit, T., Holzinger, D., Lucas, E., Ridder, R., . . . group, H.-A. s. (2021). HPV DNA genotyping, HPV E6*I mRNA detection, and p16(INK4a)/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study. Cancer Epidemiol. 72: 101925. PMID: 33839457  doi: 10.1016/j.canep.2021.101925
227. Stelzle, D., Tanaka, L. F., Lee, K. K., Ibrahim Khalil, A., Baussano, I., Shah, A. S. V., . . . Dalal, S. (2021). Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 9(2): e161-e169. PMID: 33212031  doi: 10.1016/S2214-109X(20)30459-9
228. Tota, J. E., Struyf, F., Hildesheim, A., Gonzalez, P., Ryser, M., Herrero, R., . . . Sampson, J. N. (2021). Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study. J Infect Dis. 223(9): 1576-1581. PMID: 32887990  doi: 10.1093/infdis/jiaa561
229. Villain, P., Carvalho, A. L., Lucas, E., Mosquera, I., Zhang, L., Muwonge, R., . . . Group, I. C.-I. S. (2021). Cross-sectional survey of the impact of the COVID-19 pandemic on cancer screening programs in selected low- and middle-income countries: Study from the IARC COVID-19 impact study group. Int J Cancer. 149(1): 97-107. PMID: 33533501  doi: 10.1002/ijc.33500
230. Wei, F., Gaisa, M. M., D’Souza, G., Xia, N., Giuliano, A. R., Hawes, S. E., . . . Clifford, G. M. (2021). Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies. Lancet HIV. 8(9): e531-e543. PMID: 34339628  doi: 10.1016/S2352-3018(21)00108-9
231. Xia, C., Xu, X., Zhao, X., Hu, S., Qiao, Y., Zhang, Y., . . . Zhao, F. (2021). Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study. BMC Med. 19(1): 62. PMID: 33653331  doi: 10.1186/s12916-021-01930-9
232. Yadav, K., Ginsburg, O., Basu, P., & Mehrotra, R. (2021). Telemedicine and Cancer Care in Low- and Middle-Income Countries During the SARS-CoV-2 Pandemic. JCO Glob Oncol. 7: 1633-1638. PMID: 34860567  doi: 10.1200/GO.21.00249
233. Yang, L., Kartsonaki, C., Yao, P., de Martel, C., Plummer, M., Chapman, D., . . . China Kadoorie Biobank Collaborative, G. (2021). The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study. Lancet Public Health. 6(12): e888-e896. PMID: 34838195  doi: 10.1016/S2468-2667(21)00164-X
234. Zhao, X. L., Liu, Z. H., Zhao, S., Hu, S. Y., Muwonge, R., Duan, X. Z., . . . Basu, P. (2021). Efficacy of point-of-care thermal ablation among high-risk human papillomavirus positive women in China. Int J Cancer. 148(6): 1419-1427. PMID: 32895912  doi: 10.1002/ijc.33290
235. Zhao, Y., Amorrortu, R. P., Fenske, N. A., Cherpelis, B., Messina, J. L., Sondak, V. K., . . . Rollison, D. E. (2021). Cutaneous viral infections associated with ultraviolet radiation exposure. Int J Cancer. 148(2): 448-458. PMID: 32818302  doi: 10.1002/ijc.33263
236. Alberts, C. J., Heard, I., Canestri, A., Marchand, L., Flejou, J. F., Piroth, L., . . . group, A. E. A. S. (2020). Incidence and Clearance of Anal Human Papillomavirus (HPV)-16 and HPV-18 Infection, and Their Determinants, Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in France. J Infect Dis. 221(9): 1488-1493. PMID: 31754686 doi: 10.1093/infdis/jiz623
237. Alberts, C. J., Jeske, R., de Martel, C., den Hollander, W. J., Michel, A., Prins, M., . . . Waterboer, T. (2020). Helicobacter pylori seroprevalence in six different ethnic groups living in Amsterdam: The HELIUS study. Helicobacter. 25(3): e12687. PMID: 32147867 doi: 10.1111/hel.12687
238. Albuquerque, A., Stirrup, O., Nathan, M., & Clifford, G. M. (2020). Burden of anal squamous cell carcinoma, squamous intraepithelial lesions and HPV16 infection in solid organ transplant recipients: A systematic review and meta-analysis. Am J Transplant. 20(12): 3520-3528. PMID: 32343489 doi: 10.1111/ajt.15942
239. Almonte, M., Murillo, R., Sánchez, G. I., González, P., Ferrera, A., Picconi, M. A., . . . Herrero, R. (2020). Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol. BMJ Open. 10(5): e035796. PMID: 32448795 doi: 10.1136/bmjopen-2019-035796
240. Altamura, G., Tommasino, M., & Borzacchiello, G. (2020). Cutaneous vs. Mucosal Tropism: The Papillomavirus Paradigm Comes to an « and ». Front Microbiol. 11: 588663. PMID: 33162966 doi: 10.3389/fmicb.2020.588663
241. Amorrortu, R. P., Fenske, N. A., Cherpelis, B. S., Vijayan, L., Zhao, Y., Balliu, J., . . . Rollison, D. E. (2020). Viruses in Skin Cancer (VIRUSCAN): Study Design and Baseline Characteristics of a Prospective Clinic-Based Cohort Study. Cancer Epidemiol Biomarkers Prev. 29(1): 39-48. PMID: 31427307 doi: 10.1158/1055-9965.Epi-19-0446
242. Angel, C. Z., Iguacel, I., Mullee, A., Guha, N., Wasson, R., McKenna, D. J., . . . Huybrechts, I. (2020). Appetite-regulating hormones-leptin, adiponectin and ghrelin-and the development of prostate cancer: a systematic review and exploratory meta-analysis. Prostate Cancer Prostatic Dis. 23(1): 11-23. PMID: 31147627 doi: 10.1038/s41391-019-0154-1
243. Arbyn, M., Bruni, L., Kelly, D., Basu, P., Poljak, M., Gultekin, M., . . . Weiderpass, E. (2020). Tackling cervical cancer in Europe amidst the COVID-19 pandemic. Lancet Public Health. 5(8): e425. PMID: 32673570 doi: 10.1016/s2468-2667(20)30122-5
244. Armaroli, P., Riggi, E., Basu, P., Anttila, A., Ponti, A., Carvalho, A. L., . . . Segnan, N. (2020). Performance indicators in breast cancer screening in the European Union: A comparison across countries of screen positivity and detection rates. Int J Cancer. 147(7): 1855-1863. PMID: 32159224 doi: 10.1002/ijc.32968
245. Arnold, M., Park, J. Y., Camargo, M. C., Lunet, N., Forman, D., & Soerjomataram, I. (2020). Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut. 69(5): 823-829. PMID: 32001553 doi: 10.1136/gutjnl-2019-320234
246. Baena, A., De Vuyst, H., Mesher, D., Kasubi, M., Yuma, S., Mwaiselage, J., . . . Broutet, N. (2020). Reproducibility of a Rapid Human Papillomavirus Test at Different Levels of the Healthcare System in Tanzania: The AISHA Study. Cancer Epidemiol Biomarkers Prev. 29(11): 2261-2268. PMID: 32856600 doi: 10.1158/1055-9965.EPI-20-0422
247. Bandolin, L., Borsetto, D., Fussey, J., Da Mosto, M. C., Nicolai, P., Menegaldo, A., . . . Boscolo-Rizzo, P. (2020). Beta human papillomaviruses infection and skin carcinogenesis. Rev Med Virol. 30(4): e2104. PMID: 32232924 doi: 10.1002/rmv.2104
248. Basu, M., Gupta, P., Dutta, A., Jana, K., & Ukil, A. (2020). Increased host ATP efflux and its conversion to extracellular adenosine is crucial for establishing Leishmania infection. J Cell Sci. 133(7): jcs239939. PMID: 32079656 doi: 10.1242/jcs.239939
249. Baussano, I., Sankaranarayanan, R., & Weiderpass, E. (2020). Prevention is life- and cost-saving. Prev Med. 138: 106150. PMID: 32473263 doi: 10.1016/j.ypmed.2020.106150
250. Baussano, I., Tshomo, U., Tenet, V., Heideman, D. A. M., Wangden, T., Franceschi, S., & Clifford, G. M. (2020). Prevalence of Human Papillomavirus and Estimation of Human Papillomavirus Vaccine Effectiveness in Thimphu, Bhutan, in 2011-2012 and 2018 : A Cross-sectional Study. Ann Intern Med. 173(11): 888-894. PMID: 32956600 doi: 10.7326/m20-2849
251. Bhatla, N., Meena, J., Gupta, K., Pal, B., Divakar, H., Bhalerao, S., . . . Purandare, C. N. (2020). Human papillomavirus vaccination: Good clinical practice recommendations from the Federation of Obstetric and Gynecological Societies of India. J Obstet Gynaecol Res. 46(9): 1651-1660. PMID: 32627278 doi: 10.1111/jog.14345
252. Bhatla, N., Singhal, S., Saraiya, U., Srivastava, S., Bhalerao, S., Shamsunder, S., . . . Purandare, C. N. (2020). Screening and management of preinvasive lesions of the cervix: Good clinical practice recommendations from the Federation of Obstetrics and Gynaecologic Societies of India (FOGSI). J Obstet Gynaecol Res. 46(2): 201-214. PMID: 31814222 doi: 10.1111/jog.14168
253. Butt, J., Jenab, M., Pawlita, M., Tjonneland, A., Kyro, C., Boutron-Ruault, M. C., . . . Hughes, D. J. (2020). Antibody Responses to Helicobacter pylori and Risk of Developing Colorectal Cancer in a European Cohort. Cancer Epidemiol Biomarkers Prev. 29(7): 1475-1481. PMID: 32332031 doi: 10.1158/1055-9965.EPI-19-1545
254. Castle, P. E., Pierz, A. J., Adcock, R., Aslam, S., Basu, P. S., Belinson, J. L., . . . Xi, L. F. (2020). A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus-positive and -Negative Cervical Precancers. Cancer Prev Res (Phila). 13(10): 829-840. PMID: 32655005 doi: 10.1158/1940-6207.Capr-20-0182
255. Clifford, G. M., & Combes, J. D. (2020). Hopes for Prevention of Anal Cancer in Women. J Infect Dis. 221(8): 1210-1212. PMID: 31100126 doi: 10.1093/infdis/jiz191
256. Combes, J. D., Clifford, G. M., Gunthard, H. F., Hauser, C., Darling, K. E. A., Valladares, P., . . . Swiss, H. I. V. C. S. (2020). Antibodies against HPV16E6 oncoprotein in the Swiss HIV cohort study: Kinetics and anal cancer risk prediction. Int J Cancer. 147(3): 757-765. PMID: 31722114 doi: 10.1002/ijc.32784
257. Cordova, R., Knaze, V., Viallon, V., Rust, P., Schalkwijk, C. G., Weiderpass, E., . . . Freisling, H. (2020). Dietary intake of advanced glycation end products (AGEs) and changes in body weight in European adults. Eur J Nutr. 59(7): 2893-2904. PMID: 31701336 doi: 10.1007/s00394-019-02129-8
258. Cuzick, J., Adcock, R., Carozzi, F., Gillio-Tos, A., De Marco, L., Del Mistro, A., . . . Ronco, G. (2020). Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening. Int J Cancer. 147(7): 1864-1873. PMID: 32170961 doi: 10.1002/ijc.32973
259. de Carvalho, A. C., Perdomo, S., Dos Santos, W., Fernandes, G. C., de Jesus, L. M., Carvalho, R. S., . . . Carvalho, A. L. (2020). Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma. Sci Rep. 10(1): 9970. PMID: 32561788 doi: 10.1038/s41598-020-66741-z
260. de Martel, C., Georges, D., Bray, F., Ferlay, J., & Clifford, G. M. (2020). Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 8(2): e180-e190. PMID: 31862245 doi: 10.1016/s2214-109x(19)30488-7
261. Di Credico, G., Polesel, J., Dal Maso, L., Pauli, F., Torelli, N., Luce, D., . . . Edefonti, V. (2020). Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration. Br J Cancer. 123(9): 1456-1463. PMID: 32830199 doi: 10.1038/s41416-020-01031-z
262. Duan, R., Qiao, Y., Clifford, G., & Zhao, F. (2020). Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China. Cancer Med. 9(1): 374-384. PMID: 31714036 doi: 10.1002/cam4.2697
263. Galati, L., Brancaccio, R. N., Robitaille, A., Cuenin, C., Luzi, F., Fiorucci, G., . . . Tommasino, M. (2020). Detection of human papillomaviruses in paired healthy skin and actinic keratosis by next generation sequencing. Papillomavirus Res. 9: 100196. PMID: 32222599 doi: 10.1016/j.pvr.2020.100196
264. Galati, L., Combes, J. D., Gupta, P., Sen, R., Robitaille, A., Brancaccio, R. N., . . . Tommasino, M. (2020). Detection of a large spectrum of viral infections in conjunctival premalignant and malignant lesions. Int J Cancer. 147(10): 2862-2870. PMID: 32525572 doi: 10.1002/ijc.33149
265. Gasenko, E., Leja, M., Polaka, I., Hegmane, A., Murillo, R., Bordin, D., . . . Haick, H. (2020). How do international gastric cancer prevention guidelines influence clinical practice globally? Eur J Cancer Prev. 29(5): 400-407. PMID: 32740165 doi: 10.1097/CEJ.0000000000000580
266. Gheit, T., Rollo, F., Brancaccio, R. N., Robitaille, A., Galati, L., Giuliani, M., . . . Dona, M. G. (2020). Oral Infection by Mucosal and Cutaneous Human Papillomaviruses in the Men Who Have Sex with Men from the OHMAR Study. Viruses. 12(8): 15. PMID: 32824507 doi: 10.3390/v12080899
267. Gupta, P., Shahzad, N., Harold, A., Shuda, M., Venuti, A., Romero-Medina, M. C., . . . Tommasino, M. (2020). Merkel Cell Polyomavirus Downregulates N-myc Downstream-Regulated Gene 1, Leading to Cellular Proliferation and Migration. J Virol. 94(3): e00899-00819. PMID: 31694959 doi: 10.1128/jvi.00899-19
268. Herrero, R., Heise, K., Acevedo, J., Cook, P., Gonzalez, C., Gahona, J., . . . Ferreccio, C. (2020). Regional variations in Helicobacter pylori infection, gastric atrophy and gastric cancer risk: The ENIGMA study in Chile. PLoS ONE. 15(9): e0237515. PMID: 32898138 doi: 10.1371/journal.pone.0237515
269. Honaryar, M. K., Tarasenko, Y., Almonte, M., & Smelov, V. (2020). Epidemiology of Cancers in Men Who Have Sex with Men (MSM): A Protocol for Umbrella Review of Systematic Reviews. Int J Environ Res Public Health. 17(14): 4954. PMID: 32660003 doi: 10.3390/ijerph17144954
270. Huybrechts, I., Zouiouich, S., Loobuyck, A., Vandenbulcke, Z., Vogtmann, E., Pisanu, S., . . . Michels, N. (2020). The Human Microbiome in Relation to Cancer Risk: A Systematic Review of Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 29(10): 1856-1868. PMID: 32727720 doi: 10.1158/1055-9965.EPI-20-0288
271. Jia, M., Lin, X., Zhou, X., Yan, H., Chen, Y., Liu, P., . . . Sankaranarayanan, R. (2020). Diagnostic performance of automated breast ultrasound and handheld ultrasound in women with dense breasts. Breast Cancer Res Treat. 181(3): 589-597. PMID: 32338323 doi: 10.1007/s10549-020-05625-2
272. Joshi, S., Mane, A., Muwonge, R., Divate, U., Padbidri, V., Kulkarni, V., . . . Sankaranarayanan, R. (2020). Prevalence and predictors of bacterial vaginosis in HIV-infected women in Maharashtra, India. Int J STD AIDS. 31(6): 541-552. PMID: 32233718 doi: 10.1177/0956462419878333
273. Kowalski, L. P., Sanabria, A., Ridge, J. A., Ng, W. T., de Bree, R., Rinaldo, A., . . . Ferlito, A. (2020). COVID-19 pandemic: Effects and evidence-based recommendations for otolaryngology and head and neck surgery practice. Head Neck. 42(6): 1259-1267. PMID: 32270581 doi: 10.1002/hed.26164
274. Kreimer, A. R., Sampson, J. N., Porras, C., Schiller, J. T., Kemp, T., Herrero, R., . . . Pinto, L. A. (2020). Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial. J Natl Cancer Inst. 112(10): 1038-1046. PMID: 32091594 doi: 10.1093/jnci/djaa011
275. Kumar, S., Khanduri, A., Sidibe, A., Morgan, C., Torode, J., Basu, P., . . . Bloem, P. (2020). Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low- and lower-middle-income countries. Int J Gynaecol Obstet. 152(1): 32-39. PMID: 33185283 doi: 10.1002/ijgo.13482
276. Lambert, P. F., Munger, K., Rosl, F., Hasche, D., & Tommasino, M. (2020). Beta human papillomaviruses and skin cancer. Nature. 588(7838): E20-E21. PMID: 33328661 doi: 10.1038/s41586-020-3023-0
277. Larose, T. L., Meheus, F., Brennan, P., Johansson, M., & Robbins, H. A. (2020). Assessment of Biomarker Testing for Lung Cancer Screening Eligibility. JAMA Netw Open. 3(3): e200409. PMID: 32134462 doi: 10.1001/jamanetworkopen.2020.0409
278. Li, M., Sun, Y., Yang, J., de Martel, C., Charvat, H., Clifford, G. M., . . . Wang, L. (2020). Time trends and other sources of variation in Helicobacter pylori infection in mainland China: A systematic review and meta-analysis. Helicobacter. 25(5): e12729. PMID: 32686261 doi: 10.1111/hel.12729
279. Liu, Z., Lin, C., Mu, L., Suo, C., Ye, W., Jin, L., . . . Chen, X. (2020). The disparities in gastrointestinal cancer incidence among Chinese populations in Shanghai compared to Chinese immigrants and indigenous non-Hispanic white populations in Los Angeles, USA. Int J Cancer. 146(2): 329-340. PMID: 30838637 doi: 10.1002/ijc.32251
280. Lortet-Tieulent, J., Georges, D., Bray, F., & Vaccarella, S. (2020). Profiling global cancer incidence and mortality by socioeconomic development. Int J Cancer. 147(11): 3029-3036. PMID: 32449164 doi: 10.1002/ijc.33114
281. Louvanto, K., Eriksson, T., Gray, P., Apter, D., Baussano, I., Bly, A., . . . Lehtinen, M. (2020). Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women. Int J Cancer. 147(2): 440-447. PMID: 31749143 doi: 10.1002/ijc.32802
282. Mandal, R., Ghosh, I., Banerjee, D., Mittal, S., Muwonge, R., Roy, C., . . . Basu, P. (2020). Correlation Between p16/Ki-67 Expression and the Grade of Cervical Intraepithelial Neoplasias. Int J Gynecol Pathol. 39(4): 384-390. PMID: 32515923 doi: 10.1097/PGP.0000000000000617
283. Mariz, F. C., Bender, N., Anantharaman, D., Basu, P., Bhatla, N., Pillai, M. R., . . . Lehtinen, M. (2020). Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines. Npj Vaccines. 5(1): 14. PMID: 33580075 doi: 10.1038/s41541-020-0165-x
284. Mpunga, T., Chantal Umulisa, M., Tenet, V., Rugwizangoga, B., Milner, D. A., Jr., Munyanshongore, C., . . . Clifford, G. M. (2020). Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status. Int J Cancer. 146(6): 1514-1522. PMID: 31173641 doi: 10.1002/ijc.32491
285. Muwonge, R., Basu, P., Gheit, T., Anantharaman, D., Verma, Y., Bhatla, N., . . . Indian, H. P. V. v. s. g. (2020). Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study. PLoS ONE. 15(12): e0244242. PMID: 33373380 doi: 10.1371/journal.pone.0244242
286. Nyitray, A. G., D’Souza, G., Stier, E. A., Clifford, G., & Chiao, E. Y. (2020). The Utility of Digital Anal Rectal Examinations in a Public Health Screening Program for Anal Cancer. J Low Genit Tract Dis. 24(2): 192-196. PMID: 31972661 doi: 10.1097/LGT.0000000000000508
287. Ortmann, O., Torode, J., Schmiegel, W., Thomssen, C., Hakama, M., Basu, P., . . . participants of the, E. (2020). Knowledge transfer as a tool towards improvement of cancer care in low- and middle-income countries. 6th European Roundtable Meeting (ERTM), June 14th, 2019, Berlin, Germany. J Cancer Res Clin Oncol. 146(7): 1813-1818. PMID: 32270287 doi: 10.1007/s00432-020-03209-7
288. Panato, C., Vaccarella, S., Dal Maso, L., Basu, P., Franceschi, S., Serraino, D., . . . Mathew, A. (2020). Thyroid Cancer Incidence in India Between 2006 and 2014 and Impact of Overdiagnosis. J Clin Endocrinol Metab. 105(8): 2507-2514. PMID: 32297630 doi: 10.1210/clinem/dgaa192
289. Perez-Guzman, P. N., Chung, M. H., De Vuyst, H., Dalal, S., Mutai, K. K., Muthoni, K., . . . Smit, M. (2020). The impact of scaling up cervical cancer screening and treatment services among women living with HIV in Kenya: a modelling study. BMJ Glob Health. 5(3): e001886. PMID: 32337077 doi: 10.1136/bmjgh-2019-001886
290. Pilleron, S., Cabasag, C. J., Ferlay, J., Bray, F., Luciani, S., Almonte, M., & Pineros, M. (2020). Cervical cancer burden in Latin America and the Caribbean: Where are we? Int J Cancer. 147(6): 1638-1648. PMID: 32150288 doi: 10.1002/ijc.32956
291. Pinder, L. F., Parham, G. P., Basu, P., Muwonge, R., Lucas, E., Nyambe, N., . . . Prendiville, W. (2020). Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. Lancet Oncol. 21(1): 175-184. PMID: 31734069 doi: 10.1016/s1470-2045(19)30635-7
292. Pinheiro, M., Gage, J. C., Clifford, G. M., Demarco, M., Cheung, L. C., Chen, Z., . . . Mirabello, L. (2020). Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention. Int J Cancer. 147(10): 2677-2686. PMID: 32363580 doi: 10.1002/ijc.33033
293. Poli, U. R., Muwonge, R., Bhoopal, T., Lucas, E., & Basu, P. (2020). Feasibility, Acceptability, and Efficacy of a Community Health Worker-Driven Approach to Screen Hard-to-Reach Periurban Women Using Self-Sampled HPV Detection Test in India. Jco Global Oncology. 6: 658-666. PMID: 32343627 doi: 10.1200/go.20.00061
294. Ponti, A., Basu, P., Ritchie, D., Anttila, A., Carvalho, A. L., Senore, C., . . . Segnan, N. (2020). Key issues that need to be considered while revising the current annex of the European Council Recommendation (2003) on cancer screening. Int J Cancer. 147(1): 9-13. PMID: 31970768 doi: 10.1002/ijc.32885
295. Porras, C., Tsang, S. H., Herrero, R., Guillén, D., Darragh, T. M., Stoler, M. H., . . . Kreimer, A. R. (2020). Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial. Lancet Oncol. 21(12): 1643-1652. PMID: 33271093 doi: 10.1016/s1470-2045(20)30524-6
296. Preti, M., Rotondo, J. C., Holzinger, D., Micheletti, L., Gallio, N., McKay-Chopin, S., . . . Gheit, T. (2020). Role of human papillomavirus infection in the etiology of vulvar cancer in Italian women. Infect Agent Cancer. 15: 20. PMID: 32266002 doi: 10.1186/s13027-020-00286-8
297. Qendri, V., Bogaards, J. A., Baussano, I., Lazzarato, F., Vänskä, S., & Berkhof, J. (2020). The cost-effectiveness profile of sex-neutral HPV immunisation in European tender-based settings: a model-based assessment. Lancet Public Health. 5(11): e592-e603. PMID: 33120045 doi: 10.1016/s2468-2667(20)30209-7
298. Razuka-Ebela, D., Polaka, I., Parshutin, S., Santare, D., Ebela, I., Murillo, R., . . . Leja, M. (2020). Sociodemographic, Lifestyle and Medical Factors Associated with Helicobacter Pylori Infection. J Gastrointestin Liver Dis. 29(3): 319-327. PMID: 32919416 doi: 10.15403/jgld-870
299. Razuka-Ebela, D., Zile, I., Tzivian, L., Ebela, I., Polaka, I., Parshutin, S., . . . Leja, M. (2020). Does Family History of Cancer Influence Undergoing Screening and Gastrointestinal Investigations? J Gastrointestin Liver Dis. 29(4): 523-528. PMID: 33118535 doi: 10.15403/jgld-813
300. Robitaille, A., Brancaccio, R. N., Dutta, S., Rollison, D. E., Leja, M., Fischer, N., . . . Olivier, M. (2020). PVAmpliconFinder: a workflow for the identification of human papillomaviruses from high-throughput amplicon sequencing. BMC Bioinformatics. 21(1): 233. PMID: 32513098 doi: 10.1186/s12859-020-03573-8
301. Rohner, E., Butikofer, L., Schmidlin, K., Sengayi, M., Maskew, M., Giddy, J., . . . Bohlius, J. (2020). Cervical cancer risk in women living with HIV across four continents: A multicohort study. Int J Cancer. 146(3): 601-609. PMID: 31215037 doi: 10.1002/ijc.32260
302. Romero-Medina, M. C., Venuti, A., Melita, G., Robitaille, A., Ceraolo, M. G., Pacini, L., . . . Tommasino, M. (2020). Human papillomavirus type 38 alters wild-type p53 activity to promote cell proliferation via the downregulation of integrin alpha 1 expression. PLoS Pathog. 16(8): e1008792. PMID: 32813746 doi: 10.1371/journal.ppat.1008792
303. Sayinzoga, F., Umulisa, M. C., Sibomana, H., Tenet, V., Baussano, I., & Clifford, G. M. (2020). Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort. Vaccine. 38(24): 4001-4005. PMID: 32336599 doi: 10.1016/j.vaccine.2020.04.021
304. Shiko, Y., Konno, R., Konishi, H., Sauvaget, C., Ohashi, Y., & Kakizoe, T. (2020). Effectiveness of HPV vaccination against the development of high-grade cervical lesions in young Japanese women. BMC Infect Dis. 20(1): 808. PMID: 33153446 doi: 10.1186/s12879-020-05513-6
305. Stockdale, A. J., Kreuels, B., Henrion, M. Y. R., Giorgi, E., Kyomuhangi, I., de Martel, C., . . . Geretti, A. M. (2020). The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. J Hepatol. 73(3): 523-532. PMID: 32335166 doi: 10.1016/j.jhep.2020.04.008
306. Taghavi, K., Moono, M., Mwanahamuntu, M., Basu, P., Limacher, A., Tembo, T., . . . Bohlius, J. (2020). Screening test accuracy to improve detection of precancerous lesions of the cervix in women living with HIV: a study protocol. BMJ Open. 10(12): 9. PMID: 33371015 doi: 10.1136/bmjopen-2020-037955
307. Taghavi, K., Rohner, E., Basu, P., Low, N., Rutjes, A., & Bohlius, J. (2020). Screening test accuracy of portable devices that can be used to perform colposcopy for detecting CIN2+ in low- and middle-income countries: a systematic review and meta-analysis. BMC Womens Health. 20(1): 253. PMID: 33198721 doi: 10.1186/s12905-020-01121-3
308. Tagliabue, M., Mena, M., Maffini, F., Gheit, T., Quirós Blasco, B., Holzinger, D., . . . The Hpv-Ahead Study, G. (2020). Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD Study. Cancers (Basel). 12(12): 3567. PMID: 33260360 doi: 10.3390/cancers12123567
309. Thomas, H. J. D., Bjorkman, A. D., Myers-Smith, I. H., Elmendorf, S. C., Kattge, J., Diaz, S., . . . de Vries, F. T. (2020). Global plant trait relationships extend to the climatic extremes of the tundra biome. Nat Commun. 11(1): 1351. PMID: 32165619 doi: 10.1038/s41467-020-15014-4
310. Tota, J. E., Struyf, F., Sampson, J. N., Gonzalez, P., Ryser, M., Herrero, R., . . . Hildesheim, A. (2020). Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials. J Natl Cancer Inst. 112(8): 818-828. PMID: 31697384 doi: 10.1093/jnci/djz222
311. Tsang, S. H., Basu, P., Bender, N., Herrero, R., Kemp, T. J., Kreimer, A. R., . . . Costa Rica Vaccine Trial, G. (2020). Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines. Vaccine. 38(38): 5997-6006. PMID: 32713678 doi: 10.1016/j.vaccine.2020.07.017
312. Tsang, S. H., Sampson, J. N., Schussler, J., Porras, C., Wagner, S., Boland, J., . . . Herrero, R. (2020). Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial. J Natl Cancer Inst. 112(10): 1030-1037. PMID: 32091596 doi: 10.1093/jnci/djaa010
313. Urrea Cosme, Y., Córdoba Sánchez, V., Sánchez, G. I., Baena, A., Ruiz Osorio, M. A., Rodríguez Zabala, D., & Garcés-Palacio, I. C. (2020). Health-related quality of life of women after HPV testing as triage strategy for an abnormal Pap smear: a nested randomized pragmatic trial in a middle-income country. Qual Life Res. 29(11): 2999-3008. PMID: 32617889 doi: 10.1007/s11136-020-02563-w
314. Usyk, M., Zolnik, C. P., Castle, P. E., Porras, C., Herrero, R., Gradissimo, A., . . . Costa Rica, H. P. V. V. T. G. (2020). Cervicovaginal microbiome and natural history of HPV in a longitudinal study. PLoS Pathog. 16(3): e1008376. PMID: 32214382 doi: 10.1371/journal.ppat.1008376
315. Vänskä, S., Luostarinen, T., Baussano, I., Apter, D., Eriksson, T., Natunen, K., . . . Lehtinen, M. (2020). Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied. J Infect Dis. 222(6): 948-956. PMID: 32161969 doi: 10.1093/infdis/jiaa099
316. Whitworth, H. S., Gallagher, K. E., Howard, N., Mounier-Jack, S., Mbwanji, G., Kreimer, A. R., . . . Watson-Jones, D. (2020). Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials. Vaccine. 38(6): 1302-1314. PMID: 31870572 doi: 10.1016/j.vaccine.2019.12.017
317. Wisnuwardani, R. W., De Henauw, S., Ferrari, M., Forsner, M., Gottrand, F., Huybrechts, I., . . . Michels, N. (2020). Total Polyphenol Intake Is Inversely Associated with a Pro/Anti-Inflammatory Biomarker Ratio in European Adolescents of the HELENA Study. J Nutr. 150(6): 1610-1618. PMID: 32221603 doi: 10.1093/jn/nxaa064
318. Wisnuwardani, R. W., De Henauw, S., Forsner, M., Gottrand, F., Huybrechts, I., Knaze, V., . . . Michels, N. (2020). Polyphenol intake and metabolic syndrome risk in European adolescents: the HELENA study. Eur J Nutr. 59(2): 801-812. PMID: 30903362 doi: 10.1007/s00394-019-01946-1
319. Zhao, X. L., Xu, X. Q., Duan, X. Z., Rezhake, R., Hu, S. Y., Wang, Y., . . . Basu, P. (2020). Comparative performance evaluation of different HPV tests and triaging strategies using self-samples and feasibility assessment of thermal ablation in ‘colposcopy and treat’ approach: A population-based study in rural China. Int J Cancer. 147(5): 1275-1285. PMID: 31970767 doi: 10.1002/ijc.32881
320. Zhu, B., Xiao, Y., Yeager, M., Clifford, G., Wentzensen, N., Cullen, M., . . . Mirabello, L. (2020). Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance. Nat Commun. 11(1): 886. PMID: 32060290 doi: 10.1038/s41467-020-14730-1